Frequencies for first 10,000 rows of pt variable in reac2004q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 7 0.07 0.07 ABDOMINAL ABSCESS | 1 0.01 0.08 ABDOMINAL ADHESIONS | 2 0.02 0.10 ABDOMINAL DISCOMFORT | 7 0.07 0.17 ABDOMINAL DISTENSION | 14 0.14 0.31 ABDOMINAL HAEMATOMA | 1 0.01 0.32 ABDOMINAL HERNIA | 3 0.03 0.35 ABDOMINAL INJURY | 1 0.01 0.36 ABDOMINAL PAIN | 39 0.39 0.75 ABDOMINAL PAIN LOWER | 3 0.03 0.78 ABDOMINAL PAIN UPPER | 24 0.24 1.02 ABDOMINAL REBOUND TENDERNESS | 1 0.01 1.03 ABDOMINAL TENDERNESS | 2 0.02 1.05 ABDOMINAL WALL ABSCESS | 1 0.01 1.06 ABNORMAL BEHAVIOUR | 20 0.20 1.26 ABNORMAL DREAMS | 1 0.01 1.27 ABNORMAL FAECES | 3 0.03 1.30 ABORTION | 2 0.02 1.32 ABORTION INDUCED | 3 0.03 1.35 ABORTION MISSED | 3 0.03 1.38 ABORTION SPONTANEOUS | 6 0.06 1.44 ABSCESS | 2 0.02 1.46 ACCIDENT | 3 0.03 1.49 ACCIDENTAL DEATH | 1 0.01 1.50 ACCIDENTAL EXPOSURE | 3 0.03 1.53 ACCIDENTAL OVERDOSE | 12 0.12 1.65 ACCOMMODATION DISORDER | 1 0.01 1.66 ACETABULUM FRACTURE | 1 0.01 1.67 ACID FAST BACILLI INFECTION | 1 0.01 1.68 ACID FAST STAIN POSITIVE | 1 0.01 1.69 ACINETOBACTER INFECTION | 1 0.01 1.70 ACNE | 3 0.03 1.73 ACQUIRED PYLORIC STENOSIS | 1 0.01 1.74 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 4 0.04 1.78 ACTIVITIES OF DAILY LIVING IMPAIRED | 4 0.04 1.82 ACUTE CORONARY SYNDROME | 1 0.01 1.83 ACUTE LEUKAEMIA | 1 0.01 1.84 ACUTE MYELOID LEUKAEMIA | 2 0.02 1.86 ACUTE MYOCARDIAL INFARCTION | 16 0.16 2.02 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 2.03 ACUTE PULMONARY OEDEMA | 3 0.03 2.06 ACUTE RESPIRATORY DISTRESS SYNDROME | 12 0.12 2.18 ACUTE RESPIRATORY FAILURE | 2 0.02 2.20 ACUTE SINUSITIS | 1 0.01 2.21 ACUTE TONSILLITIS | 1 0.01 2.22 ADENOMYOSIS | 1 0.01 2.23 ADHERENT LEUKOMA | 1 0.01 2.24 ADRENAL ADENOMA | 2 0.02 2.26 ADRENAL CORTEX ATROPHY | 1 0.01 2.27 ADRENAL CYST | 1 0.01 2.28 ADRENAL DISORDER | 1 0.01 2.29 ADRENAL INSUFFICIENCY | 1 0.01 2.30 ADVERSE DRUG REACTION | 6 0.06 2.36 ADVERSE EVENT | 26 0.26 2.62 AFFECT LABILITY | 2 0.02 2.64 AFFECTIVE DISORDER | 1 0.01 2.65 AGEUSIA | 3 0.03 2.68 AGGRESSION | 23 0.23 2.91 AGITATION | 27 0.27 3.18 AGRANULOCYTOSIS | 4 0.04 3.22 AKATHISIA | 2 0.02 3.24 AKINESIA | 3 0.03 3.27 ALANINE AMINOTRANSFERASE INCREASED | 44 0.44 3.71 ALCOHOL POISONING | 2 0.02 3.73 ALCOHOL PROBLEM | 1 0.01 3.74 ALCOHOLISM | 1 0.01 3.75 ALDOLASE INCREASED | 2 0.02 3.77 ALLERGIC GRANULOMATOUS ANGIITIS | 2 0.02 3.79 ALLERGIC SINUSITIS | 1 0.01 3.80 ALOPECIA | 18 0.18 3.98 AMENORRHOEA | 1 0.01 3.99 AMIMIA | 1 0.01 4.00 AMNESIA | 19 0.19 4.19 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.20 ANAEMIA | 41 0.41 4.61 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 4.62 ANAEMIA MACROCYTIC | 1 0.01 4.63 ANAEMIA OF CHRONIC DISEASE | 1 0.01 4.64 ANAL FISSURE | 2 0.02 4.66 ANAL FISTULA | 1 0.01 4.67 ANAL HAEMORRHAGE | 1 0.01 4.68 ANALGESIC DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 4.69 ANAPHYLACTIC REACTION | 6 0.06 4.75 ANAPHYLACTIC SHOCK | 11 0.11 4.86 ANAPLASTIC ASTROCYTOMA | 1 0.01 4.87 ANDROGEN DEFICIENCY | 1 0.01 4.88 ANEURYSM | 4 0.04 4.92 ANGER | 10 0.10 5.02 ANGINA PECTORIS | 22 0.22 5.24 ANGINA UNSTABLE | 4 0.04 5.28 ANGIONEUROTIC OEDEMA | 7 0.07 5.35 ANGIOPATHY | 3 0.03 5.38 ANGIOPLASTY | 1 0.01 5.39 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.40 ANHEDONIA | 4 0.04 5.44 ANION GAP INCREASED | 1 0.01 5.45 ANISOCYTOSIS | 2 0.02 5.47 ANKLE FRACTURE | 2 0.02 5.49 ANKYLOSING SPONDYLITIS | 1 0.01 5.50 ANOREXIA | 27 0.27 5.77 ANOSMIA | 5 0.05 5.82 ANOVULATORY CYCLE | 1 0.01 5.83 ANOXIC ENCEPHALOPATHY | 1 0.01 5.84 ANTI-HBE ANTIBODY POSITIVE | 1 0.01 5.85 ANTI-THYROID ANTIBODY | 1 0.01 5.86 ANTIBODY TEST POSITIVE | 1 0.01 5.87 ANTICOAGULATION DRUG LEVEL BELOW THER.. | 1 0.01 5.88 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 5.89 ANTICONVULSANT DRUG LEVEL DECREASED | 2 0.02 5.91 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 5.92 ANTINUCLEAR ANTIBODY POSITIVE | 8 0.08 6.00 ANURIA | 1 0.01 6.01 ANXIETY | 48 0.48 6.49 ANXIETY DISORDER | 2 0.02 6.51 AORTIC ANEURYSM | 2 0.02 6.53 AORTIC ANEURYSM REPAIR | 1 0.01 6.54 AORTIC ATHEROSCLEROSIS | 1 0.01 6.55 AORTIC DISSECTION | 1 0.01 6.56 AORTIC OCCLUSION | 1 0.01 6.57 AORTIC VALVE CALCIFICATION | 1 0.01 6.58 AORTIC VALVE DISEASE | 1 0.01 6.59 AORTIC VALVE INCOMPETENCE | 6 0.06 6.65 AORTIC VALVE REPLACEMENT | 1 0.01 6.66 AORTIC VALVE SCLEROSIS | 1 0.01 6.67 AORTIC VALVE STENOSIS | 1 0.01 6.68 APALLIC SYNDROME | 1 0.01 6.69 APATHY | 3 0.03 6.72 APGAR SCORE LOW | 3 0.03 6.75 APHAGIA | 1 0.01 6.76 APHASIA | 9 0.09 6.85 APHONIA | 2 0.02 6.87 APNOEA | 4 0.04 6.91 APPENDICITIS | 2 0.02 6.93 APPETITE DISORDER | 1 0.01 6.94 APPLICATION SITE BLEEDING | 1 0.01 6.95 APPLICATION SITE BURNING | 1 0.01 6.96 APPLICATION SITE DERMATITIS | 1 0.01 6.97 APPLICATION SITE DESQUAMATION | 1 0.01 6.98 APPLICATION SITE DISCHARGE | 1 0.01 6.99 APPLICATION SITE ERYTHEMA | 2 0.02 7.01 APPLICATION SITE INFLAMMATION | 1 0.01 7.02 APPLICATION SITE PIGMENTATION CHANGES | 1 0.01 7.03 APPLICATION SITE PRURITUS | 2 0.02 7.05 APPLICATION SITE REACTION | 1 0.01 7.06 APPLICATION SITE WARMTH | 1 0.01 7.07 ARACHNOIDITIS | 1 0.01 7.08 AREFLEXIA | 2 0.02 7.10 ARRHYTHMIA | 22 0.22 7.32 ARRHYTHMIA SUPRAVENTRICULAR | 3 0.03 7.35 ARTERIAL DISORDER | 1 0.01 7.36 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 7.38 ARTERIAL STENOSIS | 2 0.02 7.40 ARTERIAL STENOSIS LIMB | 1 0.01 7.41 ARTERIAL THROMBOSIS | 1 0.01 7.42 ARTERIOPATHIC DISEASE | 1 0.01 7.43 ARTERIOSCLEROSIS | 6 0.06 7.49 ARTERIOSPASM CORONARY | 1 0.01 7.50 ARTHRALGIA | 41 0.41 7.91 ARTHRITIS | 7 0.07 7.98 ARTHRITIS BACTERIAL | 1 0.01 7.99 ARTHRITIS INFECTIVE | 2 0.02 8.01 ARTHROPATHY | 4 0.04 8.05 ARTHROPOD BITE | 2 0.02 8.07 ASCITES | 11 0.11 8.18 ASEPTIC NECROSIS BONE | 1 0.01 8.19 ASPARTATE AMINOTRANSFERASE INCREASED | 45 0.45 8.64 ASPERGILLOSIS | 2 0.02 8.66 ASPERMIA | 1 0.01 8.67 ASPIRATION | 11 0.11 8.78 ASPIRATION BONE MARROW ABNORMAL | 1 0.01 8.79 ASPIRATION PLEURAL CAVITY | 1 0.01 8.80 ASTERIXIS | 3 0.03 8.83 ASTHENIA | 77 0.77 9.60 ASTHMA | 13 0.13 9.73 ATAXIA | 2 0.02 9.75 ATELECTASIS | 11 0.11 9.86 ATHEROSCLEROSIS | 1 0.01 9.87 ATRIAL FIBRILLATION | 16 0.16 10.03 ATRIAL FLUTTER | 1 0.01 10.04 ATRIAL TACHYCARDIA | 1 0.01 10.05 ATRIAL THROMBOSIS | 1 0.01 10.06 ATRIOVENTRICULAR BLOCK | 4 0.04 10.10 ATRIOVENTRICULAR BLOCK COMPLETE | 4 0.04 10.14 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 10.15 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 10.16 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 10.17 ATYPICAL MYCOBACTERIAL LYMPHADENITIS | 2 0.02 10.19 AURA | 1 0.01 10.20 AUTISM | 1 0.01 10.21 AUTOIMMUNE HEPATITIS | 2 0.02 10.23 AUTOIMMUNE THROMBOCYTOPENIA | 3 0.03 10.26 AUTOIMMUNE THYROIDITIS | 3 0.03 10.29 AXILLARY MASS | 1 0.01 10.30 AZOTAEMIA | 2 0.02 10.32 BACILLUS INFECTION | 1 0.01 10.33 BACK DISORDER | 2 0.02 10.35 BACK INJURY | 3 0.03 10.38 BACK PAIN | 31 0.31 10.69 BACTERAEMIA | 1 0.01 10.70 BACTERIAL INFECTION | 8 0.08 10.78 BALANCE DISORDER | 10 0.10 10.88 BAND NEUTROPHIL COUNT INCREASED | 2 0.02 10.90 BARRETT'S OESOPHAGUS | 1 0.01 10.91 BASAL CELL CARCINOMA | 1 0.01 10.92 BASAL GANGLION DEGENERATION | 1 0.01 10.93 BASEDOW'S DISEASE | 2 0.02 10.95 BEDRIDDEN | 3 0.03 10.98 BENIGN INTRACRANIAL HYPERTENSION | 2 0.02 11.00 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 11.02 BENIGN VASCULAR NEOPLASM | 1 0.01 11.03 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 11.04 BILE DUCT CANCER | 1 0.01 11.05 BILE DUCT OBSTRUCTION | 2 0.02 11.07 BILIARY CIRRHOSIS PRIMARY | 1 0.01 11.08 BILIARY TRACT DISORDER | 2 0.02 11.10 BILIRUBIN CONJUGATED INCREASED | 9 0.09 11.19 BIOPSY BONE MARROW ABNORMAL | 2 0.02 11.21 BIOPSY COLON ABNORMAL | 1 0.01 11.22 BIOPSY KIDNEY ABNORMAL | 1 0.01 11.23 BIOPSY LIVER ABNORMAL | 1 0.01 11.24 BIOPSY SKIN ABNORMAL | 1 0.01 11.25 BIPOLAR DISORDER | 1 0.01 11.26 BIPOLAR I DISORDER | 2 0.02 11.28 BLADDER CANCER | 3 0.03 11.31 BLADDER DISORDER | 2 0.02 11.33 BLAST CELL PROLIFERATION | 1 0.01 11.34 BLEEDING TIME ABNORMAL | 1 0.01 11.35 BLEPHAROSPASM | 1 0.01 11.36 BLINDNESS | 5 0.05 11.41 BLINDNESS CORTICAL | 2 0.02 11.43 BLINDNESS TRANSIENT | 2 0.02 11.45 BLINDNESS UNILATERAL | 1 0.01 11.46 BLISTER | 7 0.07 11.53 BLOOD ALBUMIN DECREASED | 3 0.03 11.56 BLOOD ALKALINE PHOSPHATASE INCREASED | 27 0.27 11.83 BLOOD AMYLASE ABNORMAL | 1 0.01 11.84 BLOOD AMYLASE INCREASED | 6 0.06 11.90 BLOOD BICARBONATE INCREASED | 1 0.01 11.91 BLOOD BILIRUBIN INCREASED | 20 0.20 12.11 BLOOD CALCIUM DECREASED | 6 0.06 12.17 BLOOD CALCIUM INCREASED | 1 0.01 12.18 BLOOD CATECHOLAMINES ABNORMAL | 1 0.01 12.19 BLOOD CATECHOLAMINES INCREASED | 1 0.01 12.20 BLOOD CHLORIDE DECREASED | 3 0.03 12.23 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 12.24 BLOOD CHOLESTEROL INCREASED | 18 0.18 12.42 BLOOD CORTISOL INCREASED | 1 0.01 12.43 BLOOD CREATINE INCREASED | 1 0.01 12.44 BLOOD CREATINE PHOSPHOKINASE INCREASED | 25 0.25 12.69 BLOOD CREATINE PHOSPHOKINASE MB ABNOR.. | 1 0.01 12.70 BLOOD CREATININE INCREASED | 21 0.21 12.91 BLOOD CULTURE POSITIVE | 4 0.04 12.95 BLOOD DISORDER | 2 0.02 12.97 BLOOD ELECTROLYTES DECREASED | 1 0.01 12.98 BLOOD ERYTHROPOIETIN DECREASED | 1 0.01 12.99 BLOOD FIBRINOGEN INCREASED | 1 0.01 13.00 BLOOD FOLATE DECREASED | 1 0.01 13.01 BLOOD GLUCOSE DECREASED | 2 0.02 13.03 BLOOD GLUCOSE FLUCTUATION | 1 0.01 13.04 BLOOD GLUCOSE INCREASED | 20 0.20 13.24 BLOOD HUMAN CHORIONIC GONADOTROPIN AB.. | 1 0.01 13.25 BLOOD HUMAN CHORIONIC GONADOTROPIN PO.. | 1 0.01 13.26 BLOOD IMMUNOGLOBULIN A DECREASED | 1 0.01 13.27 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 13.28 BLOOD IMMUNOGLOBULIN M DECREASED | 1 0.01 13.29 BLOOD INSULIN ABNORMAL | 1 0.01 13.30 BLOOD LACTATE DEHYDROGENASE DECREASED | 2 0.02 13.32 BLOOD LACTATE DEHYDROGENASE INCREASED | 16 0.16 13.48 BLOOD LACTIC ACID INCREASED | 1 0.01 13.49 BLOOD MAGNESIUM DECREASED | 1 0.01 13.50 BLOOD MAGNESIUM INCREASED | 1 0.01 13.51 BLOOD PH DECREASED | 1 0.01 13.52 BLOOD PHOSPHORUS DECREASED | 1 0.01 13.53 BLOOD PHOSPHORUS INCREASED | 1 0.01 13.54 BLOOD POTASSIUM DECREASED | 6 0.06 13.60 BLOOD POTASSIUM INCREASED | 6 0.06 13.66 BLOOD PRESSURE DECREASED | 20 0.20 13.86 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 13.87 BLOOD PRESSURE FLUCTUATION | 1 0.01 13.88 BLOOD PRESSURE IMMEASURABLE | 1 0.01 13.89 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 13.91 BLOOD PRESSURE INCREASED | 39 0.39 14.30 BLOOD PRESSURE SYSTOLIC DECREASED | 3 0.03 14.33 BLOOD PRESSURE SYSTOLIC INCREASED | 3 0.03 14.36 BLOOD SODIUM DECREASED | 13 0.13 14.49 BLOOD SODIUM INCREASED | 1 0.01 14.50 BLOOD TEST ABNORMAL | 1 0.01 14.51 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.52 BLOOD THYROID STIMULATING HORMONE ABN.. | 1 0.01 14.53 BLOOD THYROID STIMULATING HORMONE DEC.. | 3 0.03 14.56 BLOOD THYROID STIMULATING HORMONE INC.. | 3 0.03 14.59 BLOOD TRIGLYCERIDES INCREASED | 12 0.12 14.71 BLOOD UREA INCREASED | 10 0.10 14.81 BLOOD URIC ACID INCREASED | 2 0.02 14.83 BLOOD URINE | 4 0.04 14.87 BLOODY DISCHARGE | 1 0.01 14.88 BLUE TOE SYNDROME | 1 0.01 14.89 BODY HEIGHT DECREASED | 1 0.01 14.90 BODY TEMPERATURE DECREASED | 1 0.01 14.91 BODY TEMPERATURE INCREASED | 6 0.06 14.97 BONE DEBRIDEMENT | 1 0.01 14.98 BONE DISORDER | 5 0.05 15.03 BONE EROSION | 1 0.01 15.04 BONE INFECTION | 1 0.01 15.05 BONE MARROW DEPRESSION | 15 0.15 15.20 BONE MARROW DISORDER | 1 0.01 15.21 BONE NEOPLASM MALIGNANT | 1 0.01 15.22 BONE PAIN | 5 0.05 15.27 BRACHIAL PLEXUS INJURY | 1 0.01 15.28 BRADYCARDIA | 23 0.23 15.51 BRADYCARDIA NEONATAL | 1 0.01 15.52 BRADYKINESIA | 1 0.01 15.53 BRADYPHRENIA | 1 0.01 15.54 BRADYPNOEA | 1 0.01 15.55 BRAIN DAMAGE | 1 0.01 15.56 BRAIN DEATH | 1 0.01 15.57 BRAIN HERNIATION | 4 0.04 15.61 BRAIN MASS | 1 0.01 15.62 BRAIN NATRIURETIC PEPTIDE INCREASED | 2 0.02 15.64 BRAIN OEDEMA | 1 0.01 15.65 BREAST CANCER | 2 0.02 15.67 BREAST CANCER FEMALE | 41 0.41 16.08 BREAST CANCER IN SITU | 4 0.04 16.12 BREAST CANCER METASTATIC | 4 0.04 16.16 BREAST CANCER STAGE I | 1 0.01 16.17 BREAST DISORDER | 1 0.01 16.18 BREAST MASS | 1 0.01 16.19 BREAST OEDEMA | 1 0.01 16.20 BREAST OPERATION | 1 0.01 16.21 BREAST PAIN | 4 0.04 16.25 BREAST SWELLING | 1 0.01 16.26 BREAST TENDERNESS | 3 0.03 16.29 BREATH SOUNDS DECREASED | 4 0.04 16.33 BREECH PRESENTATION | 2 0.02 16.35 BRONCHIAL INFECTION | 2 0.02 16.37 BRONCHIOLITIS | 2 0.02 16.39 BRONCHITIS | 15 0.15 16.54 BRONCHITIS ACUTE | 4 0.04 16.58 BRONCHITIS CHRONIC | 1 0.01 16.59 BRONCHOPLEURAL FISTULA | 1 0.01 16.60 BRONCHOPNEUMONIA | 4 0.04 16.64 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 16.65 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC | 1 0.01 16.66 BRONCHOSPASM | 6 0.06 16.72 BRUGADA SYNDROME | 1 0.01 16.73 BUNDLE BRANCH BLOCK | 3 0.03 16.76 BUNDLE BRANCH BLOCK LEFT | 3 0.03 16.79 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 16.81 BURN OESOPHAGEAL | 2 0.02 16.83 BURNING SENSATION | 12 0.12 16.95 BURSITIS | 2 0.02 16.97 BURSITIS INFECTIVE | 1 0.01 16.98 C-REACTIVE PROTEIN INCREASED | 15 0.15 17.13 CAESAREAN SECTION | 5 0.05 17.18 CALCULUS URETERIC | 1 0.01 17.19 CAMPYLOBACTER GASTROENTERITIS | 1 0.01 17.20 CAMPYLOBACTER INFECTION | 1 0.01 17.21 CANDIDA SEPSIS | 1 0.01 17.22 CANDIDIASIS | 7 0.07 17.29 CAPILLARY LEAK SYNDROME | 1 0.01 17.30 CARCINOMA | 2 0.02 17.32 CARDIAC ARREST | 20 0.20 17.52 CARDIAC DISORDER | 22 0.22 17.74 CARDIAC FAILURE | 20 0.20 17.94 CARDIAC FAILURE ACUTE | 1 0.01 17.95 CARDIAC FAILURE CHRONIC | 2 0.02 17.97 CARDIAC FAILURE CONGESTIVE | 28 0.28 18.25 CARDIAC FIBRILLATION | 1 0.01 18.26 CARDIAC MURMUR | 3 0.03 18.29 CARDIAC OPERATION | 1 0.01 18.30 CARDIAC PACEMAKER INSERTION | 1 0.01 18.31 CARDIAC PROCEDURE COMPLICATION | 1 0.01 18.32 CARDIAC TAMPONADE | 1 0.01 18.33 CARDIAC VALVE DISEASE | 3 0.03 18.36 CARDIAC VALVE REPLACEMENT COMPLICATION | 1 0.01 18.37 CARDIAC VALVE SCLEROSIS | 1 0.01 18.38 CARDIAC VALVE VEGETATION | 1 0.01 18.39 CARDIO-RESPIRATORY ARREST | 31 0.31 18.70 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 18.71 CARDIOGENIC SHOCK | 2 0.02 18.73 CARDIOMEGALY | 17 0.17 18.90 CARDIOMYOPATHY | 5 0.05 18.95 CARDIOSPASM | 1 0.01 18.96 CARDIOVASCULAR DISORDER | 2 0.02 18.98 CAROTID ARTERY STENOSIS | 2 0.02 19.00 CAROTID BRUIT | 1 0.01 19.01 CARPAL TUNNEL SYNDROME | 3 0.03 19.04 CATARACT | 7 0.07 19.11 CATARACT NUCLEAR | 1 0.01 19.12 CATATONIA | 3 0.03 19.15 CATECHOLAMINES URINE INCREASED | 1 0.01 19.16 CATHETER RELATED COMPLICATION | 1 0.01 19.17 CATHETER RELATED INFECTION | 3 0.03 19.20 CATHETER SEPSIS | 1 0.01 19.21 CATHETER SITE CELLULITIS | 1 0.01 19.22 CATHETER SITE INFECTION | 1 0.01 19.23 CATHETER SITE OEDEMA | 1 0.01 19.24 CATHETER SITE PAIN | 1 0.01 19.25 CAUSTIC INJURY | 1 0.01 19.26 CD4 LYMPHOCYTES INCREASED | 1 0.01 19.27 CELLULITIS | 13 0.13 19.40 CENTRAL LINE INFECTION | 4 0.04 19.44 CEREBELLAR HAEMORRHAGE | 2 0.02 19.46 CEREBELLAR HYPOPLASIA | 1 0.01 19.47 CEREBELLAR SYNDROME | 1 0.01 19.48 CEREBELLAR TUMOUR | 1 0.01 19.49 CEREBRAL ARTERY EMBOLISM | 2 0.02 19.51 CEREBRAL ATHEROSCLEROSIS | 1 0.01 19.52 CEREBRAL ATROPHY | 2 0.02 19.54 CEREBRAL HAEMANGIOMA | 1 0.01 19.55 CEREBRAL HAEMATOMA | 1 0.01 19.56 CEREBRAL HAEMORRHAGE | 12 0.12 19.68 CEREBRAL INFARCTION | 8 0.08 19.76 CEREBRAL ISCHAEMIA | 6 0.06 19.82 CEREBRAL VENOUS THROMBOSIS | 1 0.01 19.83 CEREBRAL VENTRICLE DILATATION | 2 0.02 19.85 CEREBROVASCULAR ACCIDENT | 64 0.64 20.49 CEREBROVASCULAR DISORDER | 1 0.01 20.50 CERVICAL ROOT PAIN | 1 0.01 20.51 CHALAZION | 1 0.01 20.52 CHANGE OF BOWEL HABIT | 1 0.01 20.53 CHAPPED LIPS | 1 0.01 20.54 CHEST DISCOMFORT | 12 0.12 20.66 CHEST PAIN | 70 0.70 21.36 CHEST WALL PAIN | 3 0.03 21.39 CHEST X-RAY ABNORMAL | 3 0.03 21.42 CHILLS | 14 0.14 21.56 CHLAMYDIAL INFECTION | 1 0.01 21.57 CHOKING | 2 0.02 21.59 CHOKING SENSATION | 1 0.01 21.60 CHOLECYSTECTOMY | 3 0.03 21.63 CHOLECYSTITIS | 3 0.03 21.66 CHOLECYSTITIS ACUTE | 2 0.02 21.68 CHOLECYSTITIS CHRONIC | 1 0.01 21.69 CHOLELITHIASIS | 13 0.13 21.82 CHOLESTASIS | 13 0.13 21.95 CHOLESTEROL GRANULOMA | 1 0.01 21.96 CHOLESTEROSIS | 1 0.01 21.97 CHONDRITIS | 1 0.01 21.98 CHONDROCALCINOSIS PYROPHOSPHATE | 1 0.01 21.99 CHORDEE | 1 0.01 22.00 CHOREA | 2 0.02 22.02 CHROMATOPSIA | 1 0.01 22.03 CHROMATURIA | 7 0.07 22.10 CHROMOSOME ABNORMALITY | 1 0.01 22.11 CHRONIC FATIGUE SYNDROME | 3 0.03 22.14 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 22.15 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 2 0.02 22.17 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 7 0.07 22.24 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 3 0.03 22.27 CHRONIC SINUSITIS | 1 0.01 22.28 CIRCULATORY COLLAPSE | 15 0.15 22.43 CLEFT LIP AND PALATE | 1 0.01 22.44 CLOSTRIDIAL INFECTION | 4 0.04 22.48 CLOSTRIDIUM COLITIS | 6 0.06 22.54 COAGULATION FACTOR V LEVEL DECREASED | 2 0.02 22.56 COAGULATION FACTOR VIII LEVEL ABNORMAL | 1 0.01 22.57 COAGULOPATHY | 4 0.04 22.61 COELIAC ARTERY COMPRESSION SYNDROME | 1 0.01 22.62 COGNITIVE DETERIORATION | 2 0.02 22.64 COGNITIVE DISORDER | 9 0.09 22.73 COGWHEEL RIGIDITY | 2 0.02 22.75 COLD SWEAT | 2 0.02 22.77 COLECTOMY | 1 0.01 22.78 COLITIS | 5 0.05 22.83 COLITIS COLLAGENOUS | 1 0.01 22.84 COLITIS ISCHAEMIC | 3 0.03 22.87 COLITIS ULCERATIVE | 5 0.05 22.92 COLLAGEN DISORDER | 1 0.01 22.93 COLON CANCER | 2 0.02 22.95 COLON CANCER STAGE II | 1 0.01 22.96 COLONIC HAEMORRHAGE | 1 0.01 22.97 COLONIC STENOSIS | 2 0.02 22.99 COLONOSCOPY ABNORMAL | 1 0.01 23.00 COLOSTOMY | 1 0.01 23.01 COMA | 34 0.34 23.35 COMA HEPATIC | 1 0.01 23.36 COMMINUTED FRACTURE | 1 0.01 23.37 COMMUNICATION DISORDER | 4 0.04 23.41 COMPARTMENT SYNDROME | 1 0.01 23.42 COMPLETED SUICIDE | 54 0.54 23.96 COMPLEX PARTIAL SEIZURES | 1 0.01 23.97 COMPLICATED MIGRAINE | 1 0.01 23.98 COMPLICATIONS OF MATERNAL EXPOSURE TO.. | 1 0.01 23.99 COMPUTERISED TOMOGRAM ABNORMAL | 5 0.05 24.04 CONCOMITANT DISEASE AGGRAVATED | 2 0.02 24.06 CONCOMITANT DISEASE PROGRESSION | 1 0.01 24.07 CONCUSSION | 1 0.01 24.08 CONDITION AGGRAVATED | 58 0.58 24.66 CONFUSIONAL STATE | 43 0.43 25.09 CONGENITAL ANOMALY | 5 0.05 25.14 CONGENITAL ATRIAL SEPTAL DEFECT | 1 0.01 25.15 CONGENITAL ECTOPIC BLADDER | 1 0.01 25.16 CONGENITAL HAND MALFORMATION | 1 0.01 25.17 CONGENITAL SPINAL CORD ANOMALY | 1 0.01 25.18 CONGESTIVE CARDIOMYOPATHY | 2 0.02 25.20 CONJUNCTIVAL DISCOLOURATION | 1 0.01 25.21 CONJUNCTIVITIS | 4 0.04 25.25 CONSCIOUSNESS FLUCTUATING | 1 0.01 25.26 CONSTIPATION | 18 0.18 25.44 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 25.45 CONTUSION | 5 0.05 25.50 CONVERSION DISORDER | 3 0.03 25.53 CONVULSION | 62 0.62 26.15 CONVULSIONS LOCAL | 1 0.01 26.16 COOMBS DIRECT TEST POSITIVE | 1 0.01 26.17 COOMBS TEST POSITIVE | 1 0.01 26.18 COORDINATION ABNORMAL | 4 0.04 26.22 CORNEAL DEPOSITS | 1 0.01 26.23 CORNEAL REFLEX DECREASED | 1 0.01 26.24 CORNEAL ULCER | 2 0.02 26.26 CORONARY ARTERY ATHEROSCLEROSIS | 8 0.08 26.34 CORONARY ARTERY DISEASE | 13 0.13 26.47 CORONARY ARTERY EMBOLISM | 1 0.01 26.48 CORONARY ARTERY INSUFFICIENCY | 1 0.01 26.49 CORONARY ARTERY OCCLUSION | 9 0.09 26.58 CORONARY ARTERY RESTENOSIS | 1 0.01 26.59 CORONARY ARTERY STENOSIS | 4 0.04 26.63 CORONARY ARTERY SURGERY | 3 0.03 26.66 COSTOCHONDRITIS | 2 0.02 26.68 COUGH | 33 0.33 27.01 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 27.02 CREATININE URINE DECREASED | 1 0.01 27.03 CREPITATIONS | 2 0.02 27.05 CROHN'S DISEASE | 4 0.04 27.09 CRYING | 8 0.08 27.17 CSF MYELIN BASIC PROTEIN INCREASED | 1 0.01 27.18 CULTURE URINE POSITIVE | 2 0.02 27.20 CULTURE WOUND POSITIVE | 1 0.01 27.21 CUSHING'S SYNDROME | 1 0.01 27.22 CUTANEOUS LUPUS ERYTHEMATOSUS | 2 0.02 27.24 CUTANEOUS TUBERCULOSIS | 1 0.01 27.25 CYANOSIS | 6 0.06 27.31 CYST | 2 0.02 27.33 CYSTITIS | 2 0.02 27.35 CYSTITIS HAEMORRHAGIC | 1 0.01 27.36 CYTOLYTIC HEPATITIS | 4 0.04 27.40 CYTOMEGALOVIRUS ANTIBODY POSITIVE | 1 0.01 27.41 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 4 0.04 27.45 CYTOMEGALOVIRUS GASTRITIS | 2 0.02 27.47 CYTOMEGALOVIRUS INFECTION | 3 0.03 27.50 CYTOMEGALOVIRUS OESOPHAGITIS | 2 0.02 27.52 CYTOMEGALOVIRUS TEST POSITIVE | 1 0.01 27.53 DEAFNESS | 3 0.03 27.56 DEAFNESS BILATERAL | 1 0.01 27.57 DEAFNESS UNILATERAL | 1 0.01 27.58 DEATH | 42 0.42 28.00 DEATH NEONATAL | 1 0.01 28.01 DECEREBRATION | 2 0.02 28.03 DECREASED APPETITE | 13 0.13 28.16 DECUBITUS ULCER | 1 0.01 28.17 DEEP VEIN THROMBOSIS | 12 0.12 28.29 DEHYDRATION | 27 0.27 28.56 DELAYED RECOVERY FROM ANAESTHESIA | 1 0.01 28.57 DELIRIUM | 9 0.09 28.66 DELUSION | 1 0.01 28.67 DEMENTIA | 4 0.04 28.71 DENTAL CARIES | 1 0.01 28.72 DENTAL TREATMENT | 1 0.01 28.73 DEPENDENCE | 1 0.01 28.74 DEPENDENT PERSONALITY DISORDER | 1 0.01 28.75 DEPRESSED LEVEL OF CONSCIOUSNESS | 27 0.27 29.02 DEPRESSED MOOD | 4 0.04 29.06 DEPRESSION | 51 0.51 29.57 DEPRESSIVE SYMPTOM | 1 0.01 29.58 DERMAL CYST | 1 0.01 29.59 DERMATITIS | 2 0.02 29.61 DERMATITIS ALLERGIC | 2 0.02 29.63 DERMATITIS BULLOUS | 2 0.02 29.65 DERMATITIS CONTACT | 1 0.01 29.66 DERMATITIS EXFOLIATIVE | 5 0.05 29.71 DERMATITIS INFECTED | 1 0.01 29.72 DESQUAMATION GINGIVAL | 1 0.01 29.73 DESQUAMATION MOUTH | 1 0.01 29.74 DEVICE FAILURE | 3 0.03 29.77 DEVICE INEFFECTIVE | 1 0.01 29.78 DIABETES INSIPIDUS | 2 0.02 29.80 DIABETES MELLITUS | 10 0.10 29.90 DIABETES MELLITUS INADEQUATE CONTROL | 5 0.05 29.95 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 3 0.03 29.98 DIABETIC EYE DISEASE | 1 0.01 29.99 DIABETIC KETOACIDOSIS | 1 0.01 30.00 DIALYSIS | 7 0.07 30.07 DIAPHRAGMATIC HERNIA | 1 0.01 30.08 DIARRHOEA | 66 0.66 30.74 DIARRHOEA HAEMORRHAGIC | 3 0.03 30.77 DIASTOLIC DYSFUNCTION | 2 0.02 30.79 DIET REFUSAL | 1 0.01 30.80 DIFFICULTY IN WALKING | 15 0.15 30.95 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 30.96 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 30.97 DILATATION ATRIAL | 4 0.04 31.01 DILATATION VENTRICULAR | 4 0.04 31.05 DIPLOPIA | 11 0.11 31.16 DISABILITY | 2 0.02 31.18 DISCOMFORT | 3 0.03 31.21 DISEASE PROGRESSION | 3 0.03 31.24 DISEASE RECURRENCE | 8 0.08 31.32 DISORIENTATION | 15 0.15 31.47 DISSEMINATED INTRAVASCULAR COAGULATION | 9 0.09 31.56 DISSEMINATED TUBERCULOSIS | 2 0.02 31.58 DISSOCIATION | 2 0.02 31.60 DISTURBANCE IN ATTENTION | 16 0.16 31.76 DIVERTICULITIS | 2 0.02 31.78 DIVERTICULUM | 3 0.03 31.81 DIZZINESS | 124 1.24 33.05 DIZZINESS POSTURAL | 2 0.02 33.07 DRESSLER'S SYNDROME | 1 0.01 33.08 DROOLING | 2 0.02 33.10 DROWNING | 1 0.01 33.11 DRUG ABUSER | 11 0.11 33.22 DRUG ADDICT | 1 0.01 33.23 DRUG DEPENDENCE | 10 0.10 33.33 DRUG EFFECT DECREASED | 4 0.04 33.37 DRUG ERUPTION | 5 0.05 33.42 DRUG EXPOSURE DURING PREGNANCY | 39 0.39 33.81 DRUG EXPOSURE VIA BREAST MILK | 2 0.02 33.83 DRUG HYPERSENSITIVITY | 9 0.09 33.92 DRUG INEFFECTIVE | 99 0.99 34.91 DRUG INTERACTION | 47 0.47 35.38 DRUG INTERACTION POTENTIATION | 1 0.01 35.39 DRUG INTOLERANCE | 2 0.02 35.41 DRUG LEVEL ABOVE THERAPEUTIC | 2 0.02 35.43 DRUG LEVEL BELOW THERAPEUTIC | 1 0.01 35.44 DRUG LEVEL DECREASED | 5 0.05 35.49 DRUG LEVEL INCREASED | 4 0.04 35.53 DRUG RESISTANCE | 1 0.01 35.54 DRUG SCREEN POSITIVE | 3 0.03 35.57 DRUG THERAPEUTIC INCOMPATIBILITY | 1 0.01 35.58 DRUG TOLERANCE | 1 0.01 35.59 DRUG TOXICITY | 16 0.16 35.75 DRUG WITHDRAWAL CONVULSIONS | 1 0.01 35.76 DRUG WITHDRAWAL SYNDROME | 17 0.17 35.93 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 35.95 DRY MOUTH | 8 0.08 36.03 DRY SKIN | 7 0.07 36.10 DRY THROAT | 1 0.01 36.11 DUODENAL ULCER | 3 0.03 36.14 DUODENAL ULCER HAEMORRHAGE | 2 0.02 36.16 DUODENAL ULCER PERFORATION | 1 0.01 36.17 DUODENITIS | 1 0.01 36.18 DYSAESTHESIA | 1 0.01 36.19 DYSARTHRIA | 7 0.07 36.26 DYSGEUSIA | 10 0.10 36.36 DYSGRAPHIA | 2 0.02 36.38 DYSKINESIA | 9 0.09 36.47 DYSLIPIDAEMIA | 1 0.01 36.48 DYSPEPSIA | 18 0.18 36.66 DYSPHAGIA | 12 0.12 36.78 DYSPHONIA | 1 0.01 36.79 DYSPHORIA | 1 0.01 36.80 DYSPNOEA | 118 1.18 37.98 DYSPNOEA EXACERBATED | 1 0.01 37.99 DYSPNOEA EXERTIONAL | 5 0.05 38.04 DYSPNOEA PAROXYSMAL NOCTURNAL | 1 0.01 38.05 DYSSTASIA | 4 0.04 38.09 DYSTHYMIC DISORDER | 2 0.02 38.11 DYSTONIA | 3 0.03 38.14 DYSURIA | 4 0.04 38.18 EAR INFECTION | 3 0.03 38.21 EAR PAIN | 3 0.03 38.24 EATING DISORDER | 6 0.06 38.30 ECCHYMOSIS | 1 0.01 38.31 ECG SIGNS OF MYOCARDIAL ISCHAEMIA | 1 0.01 38.32 ECHINOCOCCIASIS | 1 0.01 38.33 ECONOMIC PROBLEM | 1 0.01 38.34 ECZEMA | 7 0.07 38.41 ECZEMA IMPETIGINOUS | 1 0.01 38.42 ECZEMA INFECTED | 1 0.01 38.43 ECZEMA WEEPING | 1 0.01 38.44 EJACULATION DISORDER | 1 0.01 38.45 EJECTION FRACTION DECREASED | 3 0.03 38.48 ELECTROCARDIOGRAM ABNORMAL | 5 0.05 38.53 ELECTROCARDIOGRAM AMBULATORY | 1 0.01 38.54 ELECTROCARDIOGRAM POOR R-WAVE PROGRES.. | 1 0.01 38.55 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 38.56 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 3 0.03 38.59 ELECTROCARDIOGRAM QT PROLONGED | 5 0.05 38.64 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL | 1 0.01 38.65 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 38.66 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 38.67 ELECTROCARDIOGRAM T WAVE ABNORMAL | 1 0.01 38.68 ELECTROCARDIOGRAM T WAVE INVERSION | 4 0.04 38.72 ELECTROENCEPHALOGRAM ABNORMAL | 3 0.03 38.75 ELECTROMECHANICAL DISSOCIATION | 2 0.02 38.77 EMOTIONAL DISORDER | 4 0.04 38.81 EMOTIONAL DISTRESS | 11 0.11 38.92 EMPHYSEMA | 3 0.03 38.95 ENCEPHALITIS | 1 0.01 38.96 ENCEPHALITIS HERPES | 1 0.01 38.97 ENCEPHALITIS MENINGOCOCCAL | 1 0.01 38.98 ENCEPHALITIS VIRAL | 2 0.02 39.00 ENCEPHALOPATHY | 6 0.06 39.06 ENDOCRINE DISORDER | 1 0.01 39.07 ENDOMETRIAL CANCER | 1 0.01 39.08 ENDOMETRIAL CANCER STAGE I | 1 0.01 39.09 ENDOMETRIOSIS | 1 0.01 39.10 ENDOTOXIC SHOCK | 1 0.01 39.11 ENERGY INCREASED | 1 0.01 39.12 ENTERITIS | 1 0.01 39.13 ENTEROBACTER INFECTION | 2 0.02 39.15 ENTEROBACTER PNEUMONIA | 1 0.01 39.16 ENTEROCOCCAL INFECTION | 3 0.03 39.19 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 39.20 EOSINOPHIL COUNT INCREASED | 5 0.05 39.25 EOSINOPHILIA | 6 0.06 39.31 EOSINOPHILIC PNEUMONIA | 1 0.01 39.32 EPICONDYLITIS | 1 0.01 39.33 EPIDERMAL NECROSIS | 1 0.01 39.34 EPIDERMODYSPLASIA VERRUCIFORMIS | 1 0.01 39.35 EPIGASTRIC DISCOMFORT | 2 0.02 39.37 EPILEPSY | 7 0.07 39.44 EPISCLERITIS | 1 0.01 39.45 EPISTAXIS | 9 0.09 39.54 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 39.56 ERECTILE DYSFUNCTION | 9 0.09 39.65 EROSIVE DUODENITIS | 2 0.02 39.67 EROSIVE OESOPHAGITIS | 1 0.01 39.68 ERUCTATION | 3 0.03 39.71 ERYTHEMA | 23 0.23 39.94 ERYTHEMA MULTIFORME | 9 0.09 40.03 ERYTHEMA NODOSUM | 1 0.01 40.04 ERYTHROBLAST MORPHOLOGY ABNORMAL | 1 0.01 40.05 ERYTHROPOIESIS ABNORMAL | 1 0.01 40.06 ESCHAR | 1 0.01 40.07 ESCHERICHIA INFECTION | 2 0.02 40.09 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 40.10 ESSENTIAL TREMOR | 1 0.01 40.11 EUPHORIC MOOD | 1 0.01 40.12 EXANTHEM | 4 0.04 40.16 EXCITABILITY | 2 0.02 40.18 EXCORIATION | 5 0.05 40.23 EXERCISE TOLERANCE DECREASED | 1 0.01 40.24 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 40.25 EXTENSOR PLANTAR RESPONSE | 1 0.01 40.26 EXTRADURAL ABSCESS | 1 0.01 40.27 EXTRAPYRAMIDAL DISORDER | 5 0.05 40.32 EXTRASYSTOLES | 1 0.01 40.33 EYE DISCHARGE | 2 0.02 40.35 EYE DISORDER | 3 0.03 40.38 EYE HAEMORRHAGE | 5 0.05 40.43 EYE INFECTION | 1 0.01 40.44 EYE INFLAMMATION | 1 0.01 40.45 EYE IRRITATION | 4 0.04 40.49 EYE MOVEMENT DISORDER | 3 0.03 40.52 EYE PAIN | 7 0.07 40.59 EYE PRURITUS | 2 0.02 40.61 EYE REDNESS | 2 0.02 40.63 EYE ROLLING | 2 0.02 40.65 EYE SWELLING | 5 0.05 40.70 EYELID OEDEMA | 5 0.05 40.75 EYELID PTOSIS | 1 0.01 40.76 FACE OEDEMA | 7 0.07 40.83 FACIAL DYSMORPHISM | 1 0.01 40.84 FACIAL PALSY | 7 0.07 40.91 FACIAL PARESIS | 1 0.01 40.92 FACIAL SPASM | 1 0.01 40.93 FACTOR V DEFICIENCY | 1 0.01 40.94 FACTOR VIII DEFICIENCY | 1 0.01 40.95 FACTOR VIII INHIBITION | 1 0.01 40.96 FAECAL INCONTINENCE | 3 0.03 40.99 FAECAL OCCULT BLOOD POSITIVE | 2 0.02 41.01 FAECALITH | 1 0.01 41.02 FAECES DISCOLOURED | 6 0.06 41.08 FAECES PALE | 1 0.01 41.09 FALL | 53 0.53 41.62 FALSE POSITIVE LABORATORY RESULT | 1 0.01 41.63 FAMILY STRESS | 1 0.01 41.64 FASCIITIS | 1 0.01 41.65 FAT TISSUE INCREASED | 2 0.02 41.67 FATIGUE | 85 0.85 42.52 FATTY ACID DEFICIENCY | 1 0.01 42.53 FEAR | 3 0.03 42.56 FEBRILE BONE MARROW APLASIA | 1 0.01 42.57 FEBRILE NEUTROPENIA | 9 0.09 42.66 FEELING ABNORMAL | 33 0.33 42.99 FEELING COLD | 5 0.05 43.04 FEELING DRUNK | 1 0.01 43.05 FEELING HOT | 10 0.10 43.15 FEELING JITTERY | 1 0.01 43.16 FEELING OF DESPAIR | 1 0.01 43.17 FEELING OF RELAXATION | 1 0.01 43.18 FEELINGS OF WORTHLESSNESS | 1 0.01 43.19 FEMORAL NECK FRACTURE | 1 0.01 43.20 FIBRIN D DIMER INCREASED | 1 0.01 43.21 FIBRIN DECREASED | 1 0.01 43.22 FIBROCYSTIC BREAST DISEASE | 1 0.01 43.23 FIBROMUSCULAR DYSPLASIA | 1 0.01 43.24 FIBROMYALGIA | 1 0.01 43.25 FIBROSIS | 2 0.02 43.27 FIBULA FRACTURE | 1 0.01 43.28 FINGER AMPUTATION | 1 0.01 43.29 FISTULA | 2 0.02 43.31 FLANK PAIN | 1 0.01 43.32 FLAT AFFECT | 1 0.01 43.33 FLATULENCE | 7 0.07 43.40 FLOPPY INFANT | 1 0.01 43.41 FLUID IMBALANCE | 1 0.01 43.42 FLUID OVERLOAD | 3 0.03 43.45 FLUID RETENTION | 3 0.03 43.48 FLUSHING | 8 0.08 43.56 FOAMING AT MOUTH | 1 0.01 43.57 FOETAL ARRHYTHMIA | 1 0.01 43.58 FOETAL CARDIAC DISORDER | 1 0.01 43.59 FOETAL DISORDER | 3 0.03 43.62 FOETAL GROWTH RETARDATION | 2 0.02 43.64 FOETAL HEART RATE ABNORMAL | 1 0.01 43.65 FOETAL MALFORMATION | 2 0.02 43.67 FOETOR HEPATICUS | 2 0.02 43.69 FOLLICULITIS | 1 0.01 43.70 FOOD POISONING | 2 0.02 43.72 FOOT FRACTURE | 1 0.01 43.73 FOREIGN BODY TRAUMA | 4 0.04 43.77 FREE THYROXINE INDEX INCREASED | 1 0.01 43.78 FREQUENT BOWEL MOVEMENTS | 1 0.01 43.79 FULL BLOOD COUNT ABNORMAL | 2 0.02 43.81 FUNGAEMIA | 1 0.01 43.82 FUNGAL INFECTION | 6 0.06 43.88 FUNGAL PERITONITIS | 1 0.01 43.89 FUNGAL SEPSIS | 1 0.01 43.90 FUNGUS SPUTUM TEST POSITIVE | 2 0.02 43.92 FUNGUS URINE TEST POSITIVE | 1 0.01 43.93 FURUNCLE | 3 0.03 43.96 GAIT DISTURBANCE | 14 0.14 44.10 GALACTORRHOEA | 1 0.01 44.11 GALLBLADDER DISORDER | 3 0.03 44.14 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 28 0.28 44.42 GAMMOPATHY | 3 0.03 44.45 GANGLION | 1 0.01 44.46 GASTRECTOMY PARTIAL | 1 0.01 44.47 GASTRIC CANCER | 3 0.03 44.50 GASTRIC DISORDER | 8 0.08 44.58 GASTRIC HAEMORRHAGE | 2 0.02 44.60 GASTRIC ULCER | 4 0.04 44.64 GASTRIC ULCER PERFORATION | 2 0.02 44.66 GASTRITIS | 12 0.12 44.78 GASTRITIS EROSIVE | 3 0.03 44.81 GASTRODUODENITIS HAEMORRHAGIC | 1 0.01 44.82 GASTROENTERITIS | 6 0.06 44.88 GASTROENTERITIS VIRAL | 1 0.01 44.89 GASTROINTESTINAL CARCINOMA | 1 0.01 44.90 GASTROINTESTINAL DISORDER | 10 0.10 45.00 GASTROINTESTINAL DISORDER CONGENITAL | 1 0.01 45.01 GASTROINTESTINAL HAEMORRHAGE | 17 0.17 45.18 GASTROINTESTINAL ISCHAEMIA | 1 0.01 45.19 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 45.20 GASTROINTESTINAL MUCOSAL DISORDER | 2 0.02 45.22 GASTROINTESTINAL MUCOSAL NECROSIS | 1 0.01 45.23 GASTROINTESTINAL OEDEMA | 1 0.01 45.24 GASTROINTESTINAL PAIN | 1 0.01 45.25 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 45.26 GASTROINTESTINAL ULCER | 1 0.01 45.27 GASTROOESOPHAGEAL REFLUX DISEASE | 17 0.17 45.44 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 45.45 GENERAL PHYSICAL HEALTH DETERIORATION | 24 0.24 45.69 GENERALISED ANXIETY DISORDER | 1 0.01 45.70 GENERALISED OEDEMA | 2 0.02 45.72 GENITAL PRURITUS FEMALE | 1 0.01 45.73 GENITAL ULCERATION | 1 0.01 45.74 GINGIVAL BLEEDING | 2 0.02 45.76 GINGIVAL CYST | 1 0.01 45.77 GINGIVAL DISCOLOURATION | 1 0.01 45.78 GINGIVAL DISORDER | 2 0.02 45.80 GINGIVAL OEDEMA | 1 0.01 45.81 GINGIVAL PAIN | 1 0.01 45.82 GLAUCOMA | 3 0.03 45.85 GLOMERULONEPHRITIS | 1 0.01 45.86 GLOMERULONEPHRITIS FOCAL | 1 0.01 45.87 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 45.88 GLOMERULONEPHRITIS PROLIFERATIVE | 3 0.03 45.91 GLOSSODYNIA | 1 0.01 45.92 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 45.93 GLYCOPEPTIDE ANTIBIOTIC RESISTANT ENT.. | 2 0.02 45.95 GLYCOSYLATED HAEMOGLOBIN INCREASED | 2 0.02 45.97 GOITRE | 3 0.03 46.00 GOUT | 3 0.03 46.03 GOUTY ARTHRITIS | 1 0.01 46.04 GRAFT COMPLICATION | 1 0.01 46.05 GRAFT DYSFUNCTION | 1 0.01 46.06 GRAFT VERSUS HOST DISEASE | 2 0.02 46.08 GRAND MAL CONVULSION | 11 0.11 46.19 GRANULOCYTES ABNORMAL | 1 0.01 46.20 GRANULOCYTOPENIA | 3 0.03 46.23 GRANULOMA | 2 0.02 46.25 GRIP STRENGTH DECREASED | 2 0.02 46.27 GROWTH RETARDATION | 1 0.01 46.28 GUILLAIN-BARRE SYNDROME | 6 0.06 46.34 GUN SHOT WOUND | 3 0.03 46.37 GYNAECOMASTIA | 1 0.01 46.38 HAEMANGIOMA OF LIVER | 2 0.02 46.40 HAEMARTHROSIS | 2 0.02 46.42 HAEMATEMESIS | 8 0.08 46.50 HAEMATOCHEZIA | 9 0.09 46.59 HAEMATOCRIT DECREASED | 19 0.19 46.78 HAEMATOMA | 2 0.02 46.80 HAEMATOTOXICITY | 1 0.01 46.81 HAEMATURIA | 8 0.08 46.89 HAEMODIALYSIS | 6 0.06 46.95 HAEMODYNAMIC INSTABILITY | 1 0.01 46.96 HAEMOGLOBIN DECREASED | 37 0.37 47.33 HAEMOGLOBIN INCREASED | 1 0.01 47.34 HAEMOLYSIS | 1 0.01 47.35 HAEMOLYTIC ANAEMIA | 1 0.01 47.36 HAEMOPTYSIS | 5 0.05 47.41 HAEMORRHAGE | 18 0.18 47.59 HAEMORRHAGE INTRACRANIAL | 4 0.04 47.63 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 47.64 HAEMORRHAGIC CEREBRAL INFARCTION | 1 0.01 47.65 HAEMORRHAGIC DIATHESIS | 4 0.04 47.69 HAEMORRHAGIC STROKE | 4 0.04 47.73 HAEMORRHOIDAL HAEMORRHAGE | 2 0.02 47.75 HAEMORRHOIDS | 5 0.05 47.80 HAEMOTHORAX | 1 0.01 47.81 HAIR COLOUR CHANGES | 1 0.01 47.82 HAIR METAL TEST ABNORMAL | 1 0.01 47.83 HALITOSIS | 1 0.01 47.84 HALLUCINATION | 15 0.15 47.99 HALLUCINATION, VISUAL | 3 0.03 48.02 HALLUCINATIONS, MIXED | 1 0.01 48.03 HAND FRACTURE | 1 0.01 48.04 HEAD INJURY | 4 0.04 48.08 HEADACHE | 75 0.75 48.83 HEART INJURY | 1 0.01 48.84 HEART RATE DECREASED | 11 0.11 48.95 HEART RATE INCREASED | 26 0.26 49.21 HEART RATE IRREGULAR | 8 0.08 49.29 HEART TRANSPLANT REJECTION | 2 0.02 49.31 HEART VALVE REPLACEMENT | 1 0.01 49.32 HEAT EXHAUSTION | 1 0.01 49.33 HEAT RASH | 1 0.01 49.34 HELICOBACTER INFECTION | 1 0.01 49.35 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 49.36 HEMIANOPIA HOMONYMOUS | 1 0.01 49.37 HEMIPARESIS | 6 0.06 49.43 HEMIPLEGIA | 1 0.01 49.44 HEPATIC ARTERY THROMBOSIS | 1 0.01 49.45 HEPATIC ATROPHY | 1 0.01 49.46 HEPATIC CIRRHOSIS | 6 0.06 49.52 HEPATIC CONGESTION | 3 0.03 49.55 HEPATIC ENCEPHALOPATHY | 3 0.03 49.58 HEPATIC ENZYME INCREASED | 13 0.13 49.71 HEPATIC FAILURE | 19 0.19 49.90 HEPATIC FIBROSIS | 2 0.02 49.92 HEPATIC FUNCTION ABNORMAL | 23 0.23 50.15 HEPATIC NECROSIS | 6 0.06 50.21 HEPATIC NEOPLASM MALIGNANT | 7 0.07 50.28 HEPATIC PAIN | 1 0.01 50.29 HEPATIC STEATOSIS | 14 0.14 50.43 HEPATIC TRAUMA | 2 0.02 50.45 HEPATITIS | 16 0.16 50.61 HEPATITIS ACUTE | 1 0.01 50.62 HEPATITIS B | 5 0.05 50.67 HEPATITIS B SURFACE ANTIGEN POSITIVE | 1 0.01 50.68 HEPATITIS C | 4 0.04 50.72 HEPATITIS CHOLESTATIC | 3 0.03 50.75 HEPATITIS FULMINANT | 4 0.04 50.79 HEPATITIS GRANULOMATOUS | 2 0.02 50.81 HEPATITIS TOXIC | 1 0.01 50.82 HEPATOCELLULAR DAMAGE | 10 0.10 50.92 HEPATOMEGALY | 7 0.07 50.99 HEPATORENAL FAILURE | 1 0.01 51.00 HEPATORENAL SYNDROME | 2 0.02 51.02 HEPATOSPLENOMEGALY | 1 0.01 51.03 HEPATOTOXICITY | 6 0.06 51.09 HERNIA | 1 0.01 51.10 HERPES SIMPLEX | 5 0.05 51.15 HERPES VIRUS INFECTION | 1 0.01 51.16 HERPES ZOSTER | 6 0.06 51.22 HETEROPHORIA | 1 0.01 51.23 HIATUS HERNIA | 7 0.07 51.30 HIGH RISK PREGNANCY | 1 0.01 51.31 HIGH-PITCHED CRYING | 1 0.01 51.32 HILAR LYMPHADENOPATHY | 1 0.01 51.33 HIP ARTHROPLASTY | 1 0.01 51.34 HIP FRACTURE | 7 0.07 51.41 HISTOPLASMOSIS | 1 0.01 51.42 HOARSENESS | 5 0.05 51.47 HODGKIN'S DISEASE | 2 0.02 51.49 HOMICIDAL IDEATION | 1 0.01 51.50 HOSPITALISATION | 1 0.01 51.51 HOSTILITY | 1 0.01 51.52 HOT FLUSH | 5 0.05 51.57 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE | 2 0.02 51.59 HUMERUS FRACTURE | 1 0.01 51.60 HYDRONEPHROSIS | 1 0.01 51.61 HYPERACUSIS | 1 0.01 51.62 HYPERAESTHESIA | 2 0.02 51.64 HYPERAMMONAEMIA | 2 0.02 51.66 HYPERBILIRUBINAEMIA | 8 0.08 51.74 HYPERCALCAEMIA | 2 0.02 51.76 HYPERCALCIURIA | 1 0.01 51.77 HYPERCHOLESTEROLAEMIA | 9 0.09 51.86 HYPERCOAGULATION | 1 0.01 51.87 HYPERGLYCAEMIA | 6 0.06 51.93 HYPERHIDROSIS | 23 0.23 52.16 HYPERKALAEMIA | 8 0.08 52.24 HYPERLACTACIDAEMIA | 1 0.01 52.25 HYPERLIPIDAEMIA | 6 0.06 52.31 HYPERMAGNESAEMIA | 1 0.01 52.32 HYPERNATRAEMIA | 2 0.02 52.34 HYPERPARATHYROIDISM SECONDARY | 1 0.01 52.35 HYPERPLASIA | 1 0.01 52.36 HYPERPROLACTINAEMIA | 1 0.01 52.37 HYPERSENSITIVITY | 13 0.13 52.50 HYPERSOMNIA | 1 0.01 52.51 HYPERTELORISM OF ORBIT | 1 0.01 52.52 HYPERTENSION | 52 0.52 53.04 HYPERTENSIVE CRISIS | 4 0.04 53.08 HYPERTHERMIA | 3 0.03 53.11 HYPERTHYROIDISM | 4 0.04 53.15 HYPERTONIA | 3 0.03 53.18 HYPERTONIC BLADDER | 1 0.01 53.19 HYPERTRIGLYCERIDAEMIA | 6 0.06 53.25 HYPERTROPHIC CARDIOMYOPATHY | 3 0.03 53.28 HYPERTROPHY | 1 0.01 53.29 HYPERURICAEMIA | 1 0.01 53.30 HYPERVENTILATION | 1 0.01 53.31 HYPERVIGILANCE | 1 0.01 53.32 HYPOACUSIS | 3 0.03 53.35 HYPOAESTHESIA | 29 0.29 53.64 HYPOALBUMINAEMIA | 4 0.04 53.68 HYPOCALCAEMIA | 6 0.06 53.74 HYPOCHLORAEMIA | 1 0.01 53.75 HYPOCHROMASIA | 1 0.01 53.76 HYPOGEUSIA | 1 0.01 53.77 HYPOGLYCAEMIA | 17 0.17 53.94 HYPOGLYCAEMIC COMA | 1 0.01 53.95 HYPOGONADISM | 1 0.01 53.96 HYPOKALAEMIA | 19 0.19 54.15 HYPOKINESIA | 4 0.04 54.19 HYPOMANIA | 1 0.01 54.20 HYPONATRAEMIA | 18 0.18 54.38 HYPOPHOSPHATAEMIA | 1 0.01 54.39 HYPOPLASTIC LEFT HEART SYNDROME | 1 0.01 54.40 HYPOPROTEINAEMIA | 1 0.01 54.41 HYPOPROTHROMBINAEMIA | 1 0.01 54.42 HYPOREFLEXIA | 2 0.02 54.44 HYPOTENSION | 58 0.58 55.02 HYPOTHERMIA | 1 0.01 55.03 HYPOTHYROIDISM | 5 0.05 55.08 HYPOTONIA | 4 0.04 55.12 HYPOTONIA NEONATAL | 3 0.03 55.15 HYPOTRICHOSIS | 1 0.01 55.16 HYPOVENTILATION | 5 0.05 55.21 HYPOVITAMINOSIS | 1 0.01 55.22 HYPOVOLAEMIA | 1 0.01 55.23 HYPOVOLAEMIC SHOCK | 1 0.01 55.24 HYPOXIA | 11 0.11 55.35 IATROGENIC INJURY | 2 0.02 55.37 IDIOSYNCRATIC DRUG REACTION | 2 0.02 55.39 ILEUS | 4 0.04 55.43 ILEUS PARALYTIC | 1 0.01 55.44 ILIAC ARTERY THROMBOSIS | 1 0.01 55.45 ILIAC VEIN THROMBOSIS | 1 0.01 55.46 ILL-DEFINED DISORDER | 3 0.03 55.49 IMMOBILE | 3 0.03 55.52 IMMUNE RECONSTITUTION SYNDROME | 3 0.03 55.55 IMMUNE SYSTEM DISORDER | 3 0.03 55.58 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 2 0.02 55.60 IMMUNOSUPPRESSION | 2 0.02 55.62 IMPAIRED DRIVING ABILITY | 1 0.01 55.63 IMPAIRED GASTRIC EMPTYING | 1 0.01 55.64 IMPAIRED HEALING | 4 0.04 55.68 IMPAIRED SELF-CARE | 1 0.01 55.69 IMPAIRED WORK ABILITY | 5 0.05 55.74 IMPETIGO | 1 0.01 55.75 INADEQUATE ANALGESIA | 1 0.01 55.76 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 5 0.05 55.81 INBORN ERROR OF METABOLISM | 1 0.01 55.82 INCISIONAL HERNIA | 1 0.01 55.83 INCOHERENT | 6 0.06 55.89 INCONTINENCE | 5 0.05 55.94 INCREASED APPETITE | 2 0.02 55.96 INCREASED TENDENCY TO BRUISE | 1 0.01 55.97 INCREASED UPPER AIRWAY SECRETION | 2 0.02 55.99 INFARCTION | 3 0.03 56.02 INFECTION | 14 0.14 56.16 INFERTILITY MALE | 1 0.01 56.17 INFLAMMATION | 9 0.09 56.26 INFLAMMATORY BOWEL DISEASE | 1 0.01 56.27 INFLUENZA | 1 0.01 56.28 INFLUENZA LIKE ILLNESS | 16 0.16 56.44 INFUSION RELATED REACTION | 14 0.14 56.58 INFUSION SITE INFECTION | 1 0.01 56.59 INGROWN HAIR | 1 0.01 56.60 INGUINAL HERNIA | 1 0.01 56.61 INJECTION SITE BURNING | 1 0.01 56.62 INJECTION SITE CALCIFICATION | 1 0.01 56.63 INJECTION SITE ERYTHEMA | 2 0.02 56.65 INJECTION SITE EXTRAVASATION | 1 0.01 56.66 INJECTION SITE HAEMORRHAGE | 3 0.03 56.69 INJECTION SITE INFLAMMATION | 1 0.01 56.70 INJECTION SITE PAIN | 7 0.07 56.77 INJECTION SITE REACTION | 5 0.05 56.82 INJECTION SITE SWELLING | 1 0.01 56.83 INJURY | 20 0.20 57.03 INJURY ASPHYXIATION | 2 0.02 57.05 INSOMNIA | 40 0.40 57.45 INTENTION TREMOR | 1 0.01 57.46 INTENTIONAL MISUSE | 7 0.07 57.53 INTENTIONAL OVERDOSE | 33 0.33 57.86 INTENTIONAL SELF-INJURY | 4 0.04 57.90 INTERLEUKIN LEVEL INCREASED | 2 0.02 57.92 INTERMITTENT CLAUDICATION | 3 0.03 57.95 INTERMITTENT EXPLOSIVE DISORDER | 1 0.01 57.96 INTERNATIONAL NORMALISED RATIO ABNORMAL | 4 0.04 58.00 INTERNATIONAL NORMALISED RATIO DECREA.. | 2 0.02 58.02 INTERNATIONAL NORMALISED RATIO INCREA.. | 12 0.12 58.14 INTERSTITIAL LUNG DISEASE | 9 0.09 58.23 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 58.24 INTERVERTEBRAL DISC DEGENERATION | 5 0.05 58.29 INTERVERTEBRAL DISC DISORDER | 3 0.03 58.32 INTERVERTEBRAL DISC PROTRUSION | 5 0.05 58.37 INTERVERTEBRAL DISCITIS | 1 0.01 58.38 INTESTINAL FISTULA | 2 0.02 58.40 INTESTINAL HAEMORRHAGE | 2 0.02 58.42 INTESTINAL ISCHAEMIA | 2 0.02 58.44 INTESTINAL OBSTRUCTION | 4 0.04 58.48 INTESTINAL PERFORATION | 2 0.02 58.50 INTESTINAL STOMA | 1 0.01 58.51 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 58.52 INTRA-CEREBRAL ANEURYSM OPERATION | 1 0.01 58.53 INTRACRANIAL ANEURYSM | 2 0.02 58.55 INTRACRANIAL HYPOTENSION | 1 0.01 58.56 INTRACRANIAL INJURY | 2 0.02 58.58 INTRACRANIAL PRESSURE INCREASED | 1 0.01 58.59 INTRANASAL NUMBNESS | 1 0.01 58.60 INTRAOCULAR PRESSURE INCREASED | 2 0.02 58.62 INTRAOCULAR PRESSURE TEST | 1 0.01 58.63 INTRAOCULAR PRESSURE TEST ABNORMAL | 1 0.01 58.64 IRIS DISORDER | 1 0.01 58.65 IRIS TRANSILLUMINATION DEFECT | 1 0.01 58.66 IRON BINDING CAPACITY TOTAL DECREASED | 1 0.01 58.67 IRON DEFICIENCY | 1 0.01 58.68 IRON DEFICIENCY ANAEMIA | 6 0.06 58.74 IRRITABILITY | 9 0.09 58.83 IRRITABLE BOWEL SYNDROME | 1 0.01 58.84 ISCHAEMIA | 1 0.01 58.85 ISCHAEMIC HEPATITIS | 1 0.01 58.86 ISCHAEMIC STROKE | 3 0.03 58.89 JAUNDICE | 19 0.19 59.08 JAUNDICE NEONATAL | 1 0.01 59.09 JAW DISORDER | 3 0.03 59.12 JOINT CONTRACTURE | 1 0.01 59.13 JOINT CREPITATION | 1 0.01 59.14 JOINT DISLOCATION | 1 0.01 59.15 JOINT EFFUSION | 1 0.01 59.16 JOINT INJURY | 3 0.03 59.19 JOINT SPRAIN | 2 0.02 59.21 JOINT STIFFNESS | 3 0.03 59.24 JOINT SWELLING | 7 0.07 59.31 JOINT TUBERCULOSIS | 1 0.01 59.32 KAPOSI'S SARCOMA | 1 0.01 59.33 KELOID SCAR | 1 0.01 59.34 KERATITIS HERPETIC | 1 0.01 59.35 KERATOCONJUNCTIVITIS SICCA | 6 0.06 59.41 KETOACIDOSIS | 1 0.01 59.42 KIDNEY INFECTION | 2 0.02 59.44 KIDNEY TRANSPLANT REJECTION | 1 0.01 59.45 KLEBSIELLA INFECTION | 2 0.02 59.47 KLEBSIELLA SEPSIS | 1 0.01 59.48 LABILE BLOOD PRESSURE | 1 0.01 59.49 LABILE HYPERTENSION | 1 0.01 59.50 LABORATORY TEST ABNORMAL | 5 0.05 59.55 LACERATION | 2 0.02 59.57 LACRIMATION INCREASED | 4 0.04 59.61 LACTIC ACIDOSIS | 6 0.06 59.67 LACUNAR INFARCTION | 4 0.04 59.71 LAPAROTOMY | 2 0.02 59.73 LARGE INTESTINAL ULCER | 1 0.01 59.74 LARGE INTESTINE PERFORATION | 3 0.03 59.77 LARYNGEAL DISCOMFORT | 1 0.01 59.78 LARYNGEAL OEDEMA | 2 0.02 59.80 LARYNGEAL PAIN | 1 0.01 59.81 LARYNGITIS | 1 0.01 59.82 LARYNGOPHARYNGITIS | 1 0.01 59.83 LARYNGOSPASM | 1 0.01 59.84 LEFT VENTRICULAR FAILURE | 2 0.02 59.86 LEG AMPUTATION | 1 0.01 59.87 LEGAL PROBLEM | 1 0.01 59.88 LETHARGY | 14 0.14 60.02 LEUKAEMIA | 2 0.02 60.04 LEUKAEMIA PLASMACYTIC | 1 0.01 60.05 LEUKAEMIA RECURRENT | 1 0.01 60.06 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 60.09 LEUKOCYTOSIS | 3 0.03 60.12 LEUKODERMA | 1 0.01 60.13 LEUKOENCEPHALOPATHY | 1 0.01 60.14 LEUKOPENIA | 12 0.12 60.26 LHERMITTE'S SIGN | 1 0.01 60.27 LIBIDO DECREASED | 3 0.03 60.30 LIBIDO INCREASED | 1 0.01 60.31 LICHEN PLANUS | 5 0.05 60.36 LIGAMENT DISORDER | 1 0.01 60.37 LIGAMENT INJURY | 1 0.01 60.38 LIGAMENT SPRAIN | 1 0.01 60.39 LIGHT CHAIN ANALYSIS INCREASED | 1 0.01 60.40 LIMB DISCOMFORT | 1 0.01 60.41 LIMB INJURY | 2 0.02 60.43 LIP BLISTER | 1 0.01 60.44 LIP DRY | 1 0.01 60.45 LIPASE INCREASED | 1 0.01 60.46 LIPIDS ABNORMAL | 1 0.01 60.47 LIPIDS INCREASED | 2 0.02 60.49 LISTERIOSIS | 1 0.01 60.50 LISTLESS | 1 0.01 60.51 LIVER DISORDER | 14 0.14 60.65 LIVER FUNCTION TEST ABNORMAL | 24 0.24 60.89 LIVER TENDERNESS | 1 0.01 60.90 LIVER TRANSPLANT | 1 0.01 60.91 LIVER TRANSPLANT REJECTION | 2 0.02 60.93 LOBAR PNEUMONIA | 2 0.02 60.95 LOCAL SWELLING | 3 0.03 60.98 LOCALISED INFECTION | 2 0.02 61.00 LOCALISED OEDEMA | 4 0.04 61.04 LOCALISED OSTEOARTHRITIS | 2 0.02 61.06 LOGORRHOEA | 1 0.01 61.07 LOOSE STOOLS | 3 0.03 61.10 LOSS OF CONSCIOUSNESS | 42 0.42 61.52 LOSS OF EMPLOYMENT | 1 0.01 61.53 LOSS OF LIBIDO | 2 0.02 61.55 LOW DENSITY LIPOPROTEIN INCREASED | 6 0.06 61.61 LOWER RESPIRATORY TRACT INFECTION | 4 0.04 61.65 LUMBAR SPINAL STENOSIS | 2 0.02 61.67 LUNG ADENOCARCINOMA | 1 0.01 61.68 LUNG DISORDER | 15 0.15 61.83 LUNG HYPERINFLATION | 1 0.01 61.84 LUNG INFECTION | 3 0.03 61.87 LUNG INFECTION PSEUDOMONAL | 1 0.01 61.88 LUNG INFILTRATION | 5 0.05 61.93 LUNG INJURY | 1 0.01 61.94 LUNG NEOPLASM | 7 0.07 62.01 LUNG NEOPLASM MALIGNANT | 3 0.03 62.04 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 1 0.01 62.05 LUPUS-LIKE SYNDROME | 2 0.02 62.07 LYMPH NODE TUBERCULOSIS | 3 0.03 62.10 LYMPHADENITIS | 1 0.01 62.11 LYMPHADENOPATHY | 11 0.11 62.22 LYMPHADENOPATHY MEDIASTINAL | 2 0.02 62.24 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 62.25 LYMPHOCYTE COUNT DECREASED | 5 0.05 62.30 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 62.31 LYMPHOCYTE PERCENTAGE DECREASED | 3 0.03 62.34 LYMPHOCYTE PERCENTAGE INCREASED | 1 0.01 62.35 LYMPHOCYTE STIMULATION TEST NEGATIVE | 1 0.01 62.36 LYMPHOCYTE STIMULATION TEST POSITIVE | 4 0.04 62.40 LYMPHOMA | 8 0.08 62.48 LYMPHOMATOID PAPULOSIS | 1 0.01 62.49 LYMPHOPENIA | 3 0.03 62.52 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 62.54 MACULAR DEGENERATION | 3 0.03 62.57 MACULAR OEDEMA | 1 0.01 62.58 MAJOR DEPRESSION | 6 0.06 62.64 MALABSORPTION | 1 0.01 62.65 MALAISE | 31 0.31 62.96 MALIGNANT HYPERTENSION | 1 0.01 62.97 MALIGNANT NEOPLASM PROGRESSION | 13 0.13 63.10 MALLORY-WEISS SYNDROME | 2 0.02 63.12 MALNUTRITION | 5 0.05 63.17 MAMMOGRAM ABNORMAL | 1 0.01 63.18 MANIA | 2 0.02 63.20 MARITAL PROBLEM | 1 0.01 63.21 MARKEDLY REDUCED DIETARY INTAKE | 5 0.05 63.26 MASKED FACIES | 2 0.02 63.28 MASS | 3 0.03 63.31 MASTITIS | 1 0.01 63.32 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 63.33 MEAN CELL VOLUME INCREASED | 2 0.02 63.35 MECONIUM PERITONITIS | 1 0.01 63.36 MEDIASTINAL DISORDER | 1 0.01 63.37 MEDIASTINAL MASS | 1 0.01 63.38 MEDICAL DEVICE COMPLICATION | 2 0.02 63.40 MEDICATION ERROR | 42 0.42 63.82 MELAENA | 5 0.05 63.87 MELAS SYNDROME | 1 0.01 63.88 MEMORY IMPAIRMENT | 13 0.13 64.01 MENINGEAL DISORDER | 1 0.01 64.02 MENINGIOMA | 1 0.01 64.03 MENINGITIS | 1 0.01 64.04 MENINGITIS LEPTOSPIRAL | 1 0.01 64.05 MENINGITIS VIRAL | 2 0.02 64.07 MENINGOCELE | 1 0.01 64.08 MENOPAUSAL SYMPTOMS | 1 0.01 64.09 MENOPAUSE | 1 0.01 64.10 MENORRHAGIA | 4 0.04 64.14 MENSTRUATION IRREGULAR | 2 0.02 64.16 MENTAL DISORDER | 4 0.04 64.20 MENTAL DISORDER DUE TO A GENERAL MEDI.. | 2 0.02 64.22 MENTAL IMPAIRMENT | 6 0.06 64.28 MENTAL RETARDATION SEVERITY UNSPECIFIED | 1 0.01 64.29 MENTAL STATUS CHANGES | 9 0.09 64.38 MENTALLY LATE DEVELOPER | 1 0.01 64.39 MESENTERIC OCCLUSION | 1 0.01 64.40 METABOLIC ACIDOSIS | 4 0.04 64.44 METABOLIC ALKALOSIS | 1 0.01 64.45 METABOLIC DISORDER | 2 0.02 64.47 METABOLIC ENCEPHALOPATHY | 1 0.01 64.48 METAPLASIA | 1 0.01 64.49 METASTASES TO BONE | 2 0.02 64.51 METASTASES TO CENTRAL NERVOUS SYSTEM | 3 0.03 64.54 METASTASES TO LIVER | 1 0.01 64.55 METASTASES TO LUNG | 1 0.01 64.56 METASTASES TO RETROPERITONEUM | 1 0.01 64.57 METASTASES TO SPINE | 1 0.01 64.58 METASTASES TO THE MEDIASTINUM | 1 0.01 64.59 METASTASIS | 1 0.01 64.60 METASTATIC MALIGNANT MELANOMA | 1 0.01 64.61 METASTATIC NEOPLASM | 2 0.02 64.63 METRORRHAGIA | 2 0.02 64.65 MICROCYTOSIS | 1 0.01 64.66 MICROGNATHIA | 1 0.01 64.67 MICROGRAPHIA | 1 0.01 64.68 MICTURITION URGENCY | 2 0.02 64.70 MIGRAINE | 8 0.08 64.78 MIGRAINE WITH AURA | 1 0.01 64.79 MIOSIS | 2 0.02 64.81 MITRAL VALVE CALCIFICATION | 1 0.01 64.82 MITRAL VALVE DISEASE | 1 0.01 64.83 MITRAL VALVE INCOMPETENCE | 9 0.09 64.92 MITRAL VALVE PROLAPSE | 1 0.01 64.93 MIXED HYPERLIPIDAEMIA | 1 0.01 64.94 MOBILITY DECREASED | 3 0.03 64.97 MONARTHRITIS | 2 0.02 64.99 MONOCYTE COUNT ABNORMAL | 1 0.01 65.00 MONOCYTE COUNT INCREASED | 2 0.02 65.02 MONOCYTE PERCENTAGE INCREASED | 3 0.03 65.05 MONOCYTOSIS | 1 0.01 65.06 MONOPLEGIA | 3 0.03 65.09 MOOD ALTERED | 3 0.03 65.12 MOOD SWINGS | 9 0.09 65.21 MORBID THOUGHTS | 1 0.01 65.22 MOTOR DYSFUNCTION | 1 0.01 65.23 MOUTH HAEMORRHAGE | 3 0.03 65.26 MOUTH INJURY | 2 0.02 65.28 MOUTH ULCERATION | 2 0.02 65.30 MOVEMENT DISORDER | 8 0.08 65.38 MUCORMYCOSIS | 1 0.01 65.39 MUCOSAL EROSION | 1 0.01 65.40 MUCOSAL INFLAMMATION | 4 0.04 65.44 MUCOSAL ULCERATION | 1 0.01 65.45 MULTI-ORGAN DISORDER | 1 0.01 65.46 MULTI-ORGAN FAILURE | 20 0.20 65.66 MULTIPLE DRUG OVERDOSE | 7 0.07 65.73 MULTIPLE DRUG OVERDOSE INTENTIONAL | 3 0.03 65.76 MULTIPLE FRACTURES | 1 0.01 65.77 MULTIPLE SCLEROSIS | 12 0.12 65.89 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 65.90 MURDER | 3 0.03 65.93 MUSCLE ATROPHY | 2 0.02 65.95 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 65.96 MUSCLE CRAMP | 11 0.11 66.07 MUSCLE DISORDER | 3 0.03 66.10 MUSCLE NECROSIS | 1 0.01 66.11 MUSCLE RIGIDITY | 4 0.04 66.15 MUSCLE SPASMS | 12 0.12 66.27 MUSCLE SPASTICITY | 2 0.02 66.29 MUSCLE STRAIN | 1 0.01 66.30 MUSCLE TIGHTNESS | 2 0.02 66.32 MUSCLE TWITCHING | 2 0.02 66.34 MUSCULAR WEAKNESS | 17 0.17 66.51 MUSCULOSKELETAL DISCOMFORT | 3 0.03 66.54 MUSCULOSKELETAL PAIN | 1 0.01 66.55 MUSCULOSKELETAL STIFFNESS | 7 0.07 66.62 MUTISM | 1 0.01 66.63 MYALGIA | 40 0.40 67.03 MYDRIASIS | 2 0.02 67.05 MYELITIS | 1 0.01 67.06 MYELODYSPLASTIC SYNDROME | 5 0.05 67.11 MYELOPATHY | 2 0.02 67.13 MYOCARDIAL INFARCTION | 77 0.77 67.90 MYOCARDIAL ISCHAEMIA | 7 0.07 67.97 MYOCARDIAL RUPTURE | 1 0.01 67.98 MYOCARDITIS | 3 0.03 68.01 MYOCLONIC EPILEPSY | 1 0.01 68.02 MYOCLONUS | 4 0.04 68.06 MYOFASCIAL PAIN SYNDROME | 1 0.01 68.07 MYOGLOBIN BLOOD INCREASED | 2 0.02 68.09 MYOGLOBINURIA | 1 0.01 68.10 MYOPATHY | 2 0.02 68.12 MYOPATHY STEROID | 1 0.01 68.13 MYOSITIS | 5 0.05 68.18 NAIL DISCOLOURATION | 2 0.02 68.20 NAIL DISORDER | 3 0.03 68.23 NASAL CONGESTION | 4 0.04 68.27 NASAL DISCOMFORT | 3 0.03 68.30 NASAL SINUS DRAINAGE | 1 0.01 68.31 NASOPHARYNGITIS | 8 0.08 68.39 NAUSEA | 111 1.11 69.50 NECK INJURY | 2 0.02 69.52 NECK MASS | 1 0.01 69.53 NECK PAIN | 12 0.12 69.65 NECROLYTIC MIGRATORY ERYTHEMA | 1 0.01 69.66 NECROSIS | 5 0.05 69.71 NEGATIVE THOUGHTS | 1 0.01 69.72 NEONATAL APNOEIC ATTACK | 2 0.02 69.74 NEONATAL ASPHYXIA | 1 0.01 69.75 NEONATAL DISORDER | 4 0.04 69.79 NEONATAL HEPATOMEGALY | 1 0.01 69.80 NEONATAL RESPIRATORY DEPRESSION | 2 0.02 69.82 NEOPLASM | 1 0.01 69.83 NEOPLASM MALIGNANT | 1 0.01 69.84 NEOPLASM PROGRESSION | 1 0.01 69.85 NEOPLASM RECURRENCE | 1 0.01 69.86 NEOVASCULARISATION | 1 0.01 69.87 NEPHRITIS INTERSTITIAL | 3 0.03 69.90 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 69.91 NEPHROLITHIASIS | 8 0.08 69.99 NEPHROPATHY | 1 0.01 70.00 NEPHROPATHY TOXIC | 2 0.02 70.02 NEPHROSCLEROSIS | 2 0.02 70.04 NEPHROTIC SYNDROME | 4 0.04 70.08 NERVE CONDUCTION STUDIES ABNORMAL | 1 0.01 70.09 NERVE INJURY | 1 0.01 70.10 NERVOUS SYSTEM DISORDER | 2 0.02 70.12 NERVOUSNESS | 8 0.08 70.20 NEURALGIA | 4 0.04 70.24 NEURITIS | 3 0.03 70.27 NEUROGENIC BLADDER | 1 0.01 70.28 NEUROLEPTIC MALIGNANT SYNDROME | 6 0.06 70.34 NEUROLOGICAL SYMPTOM | 1 0.01 70.35 NEUROMYOPATHY | 1 0.01 70.36 NEUROPATHY | 2 0.02 70.38 NEUROPATHY PERIPHERAL | 6 0.06 70.44 NEUROSIS | 1 0.01 70.45 NEUROTOXICITY | 3 0.03 70.48 NEUTROPENIA | 23 0.23 70.71 NEUTROPENIC INFECTION | 1 0.01 70.72 NEUTROPENIC SEPSIS | 3 0.03 70.75 NEUTROPHIL COUNT DECREASED | 7 0.07 70.82 NEUTROPHIL PERCENTAGE DECREASED | 1 0.01 70.83 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 70.84 NEUTROPHIL TOXIC GRANULATION PRESENT | 1 0.01 70.85 NIGHT SWEATS | 8 0.08 70.93 NIGHTMARE | 7 0.07 71.00 NO ADVERSE DRUG EFFECT | 3 0.03 71.03 NO ADVERSE EFFECT | 2 0.02 71.05 NOCARDIOSIS | 2 0.02 71.07 NOCTURIA | 2 0.02 71.09 NOCTURNAL DYSPNOEA | 1 0.01 71.10 NODAL ARRHYTHMIA | 2 0.02 71.12 NODAL RHYTHM | 2 0.02 71.14 NON-CARDIAC CHEST PAIN | 4 0.04 71.18 NON-CARDIOGENIC PULMONARY OEDEMA | 1 0.01 71.19 NORMAL NEWBORN | 1 0.01 71.20 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 71.21 NYSTAGMUS | 1 0.01 71.22 OBESITY | 3 0.03 71.25 OBLITERATIVE BRONCHIOLITIS | 2 0.02 71.27 OBSESSIVE-COMPULSIVE DISORDER | 1 0.01 71.28 OBSTRUCTIVE AIRWAYS DISORDER | 3 0.03 71.31 OCULAR HYPERTENSION | 1 0.01 71.32 OCULAR ICTERUS | 2 0.02 71.34 ODYNOPHAGIA | 2 0.02 71.36 OEDEMA | 16 0.16 71.52 OEDEMA GENITAL | 1 0.01 71.53 OEDEMA MUCOSAL | 1 0.01 71.54 OEDEMA PERIPHERAL | 46 0.46 72.00 OESOPHAGEAL CANDIDIASIS | 1 0.01 72.01 OESOPHAGEAL CARCINOMA | 1 0.01 72.02 OESOPHAGEAL DISORDER | 3 0.03 72.05 OESOPHAGEAL SPASM | 2 0.02 72.07 OESOPHAGEAL ULCER | 3 0.03 72.10 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 72.11 OESOPHAGITIS | 6 0.06 72.17 OFF LABEL USE | 3 0.03 72.20 OLIGOMENORRHOEA | 1 0.01 72.21 OLIGURIA | 7 0.07 72.28 ONYCHOMADESIS | 1 0.01 72.29 ONYCHOMYCOSIS | 2 0.02 72.31 ONYCHORRHEXIS | 2 0.02 72.33 OPERATIVE HAEMORRHAGE | 1 0.01 72.34 OPHTHALMOLOGICAL EXAMINATION ABNORMAL | 1 0.01 72.35 OPPORTUNISTIC INFECTION | 1 0.01 72.36 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 72.37 OPTIC DISC DISORDER | 3 0.03 72.40 OPTIC DISC HAEMORRHAGE | 1 0.01 72.41 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 72.42 OPTIC NERVE DISORDER | 2 0.02 72.44 OPTIC NERVE SHEATH HAEMORRHAGE | 1 0.01 72.45 OPTIC NEURITIS | 1 0.01 72.46 OPTIC NEURITIS RETROBULBAR | 1 0.01 72.47 OPTIC NEUROPATHY | 1 0.01 72.48 ORAL CANDIDIASIS | 1 0.01 72.49 ORAL DISCHARGE | 1 0.01 72.50 ORAL MUCOSAL BLISTERING | 2 0.02 72.52 ORAL MUCOSAL DISORDER | 1 0.01 72.53 ORAL MUCOSAL PETECHIAE | 1 0.01 72.54 ORAL NEOPLASM | 1 0.01 72.55 ORAL PAIN | 1 0.01 72.56 ORAL SURGERY | 1 0.01 72.57 ORBITAL OEDEMA | 1 0.01 72.58 ORGAN FAILURE | 2 0.02 72.60 OROPHARYNGEAL SWELLING | 6 0.06 72.66 ORTHOPNOEA | 1 0.01 72.67 ORTHOSTATIC HYPOTENSION | 7 0.07 72.74 OSTEOARTHRITIS | 7 0.07 72.81 OSTEOCHONDROSIS | 1 0.01 72.82 OSTEOLYSIS | 2 0.02 72.84 OSTEOMYELITIS | 4 0.04 72.88 OSTEONECROSIS | 4 0.04 72.92 OSTEOPENIA | 1 0.01 72.93 OSTEOPOROSIS | 3 0.03 72.96 OTITIS MEDIA | 4 0.04 73.00 OVARIAN CANCER | 3 0.03 73.03 OVARIAN CYST | 6 0.06 73.09 OVARIAN EPITHELIAL CANCER RECURRENT | 1 0.01 73.10 OVARIAN MASS | 1 0.01 73.11 OVERDOSE | 40 0.40 73.51 OVERWEIGHT | 2 0.02 73.53 OXYGEN SATURATION DECREASED | 11 0.11 73.64 PAIN | 39 0.39 74.03 PAIN EXACERBATED | 6 0.06 74.09 PAIN IN EXTREMITY | 31 0.31 74.40 PAIN IN JAW | 3 0.03 74.43 PAIN OF SKIN | 3 0.03 74.46 PALATAL DISORDER | 1 0.01 74.47 PALLOR | 7 0.07 74.54 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 2 0.02 74.56 PALPITATIONS | 35 0.35 74.91 PANCREATIC DISORDER | 1 0.01 74.92 PANCREATIC INJURY | 1 0.01 74.93 PANCREATITIS | 6 0.06 74.99 PANCREATITIS ACUTE | 5 0.05 75.04 PANCYTOPENIA | 18 0.18 75.22 PANIC ATTACK | 7 0.07 75.29 PANIC DISORDER | 1 0.01 75.30 PANIC DISORDER WITH AGORAPHOBIA | 1 0.01 75.31 PANNICULITIS | 1 0.01 75.32 PAPILLOEDEMA | 3 0.03 75.35 PAPILLOMA | 1 0.01 75.36 PARAESTHESIA | 20 0.20 75.56 PARAKERATOSIS | 1 0.01 75.57 PARALYSIS | 6 0.06 75.63 PARALYSIS FLACCID | 2 0.02 75.65 PARANASAL SINUS HYPERSECRETION | 1 0.01 75.66 PARANOIA | 5 0.05 75.71 PARAPLEGIA | 1 0.01 75.72 PARAPROTEINAEMIA | 1 0.01 75.73 PARESIS | 1 0.01 75.74 PARKINSON'S DISEASE | 2 0.02 75.76 PARKINSONISM | 1 0.01 75.77 PAROSMIA | 3 0.03 75.80 PAROTID GLAND ENLARGEMENT | 1 0.01 75.81 PAROTITIS | 1 0.01 75.82 PARTIAL SEIZURES | 3 0.03 75.85 PATENT DUCTUS ARTERIOSUS | 1 0.01 75.86 PATHOGEN RESISTANCE | 1 0.01 75.87 PATHOLOGICAL GAMBLING | 1 0.01 75.88 PATIENT RESTRAINT | 1 0.01 75.89 PCO2 DECREASED | 1 0.01 75.90 PELVI-URETERIC OBSTRUCTION | 1 0.01 75.91 PELVIC FRACTURE | 1 0.01 75.92 PELVIC HAEMATOMA | 1 0.01 75.93 PELVIC INFECTION | 2 0.02 75.95 PEMPHIGOID | 1 0.01 75.96 PENILE PAIN | 1 0.01 75.97 PENIS DISORDER | 1 0.01 75.98 PEPTIC ULCER | 2 0.02 76.00 PEPTIC ULCER HAEMORRHAGE | 1 0.01 76.01 PEPTIC ULCER PERFORATION | 1 0.01 76.02 PEPTOSTREPTOCOCCUS INFECTION | 1 0.01 76.03 PERFORATED ULCER | 1 0.01 76.04 PERFORMANCE STATUS DECREASED | 2 0.02 76.06 PERICARDIAL EFFUSION | 6 0.06 76.12 PERICARDIAL HAEMORRHAGE | 1 0.01 76.13 PERICARDITIS | 1 0.01 76.14 PERICARDITIS CONSTRICTIVE | 1 0.01 76.15 PERICARDITIS TUBERCULOUS | 1 0.01 76.16 PERIPHERAL COLDNESS | 8 0.08 76.24 PERIPHERAL ISCHAEMIA | 2 0.02 76.26 PERIPHERAL OCCLUSIVE DISEASE | 1 0.01 76.27 PERIPHERAL VASCULAR DISORDER | 4 0.04 76.31 PERIRECTAL ABSCESS | 1 0.01 76.32 PERITONEAL CARCINOMA | 1 0.01 76.33 PERITONEAL DIALYSIS | 2 0.02 76.35 PERITONITIS | 7 0.07 76.42 PERITONITIS BACTERIAL | 1 0.01 76.43 PERNICIOUS ANAEMIA | 1 0.01 76.44 PERSECUTORY DELUSION | 1 0.01 76.45 PERSONALITY CHANGE | 5 0.05 76.50 PERSONALITY CHANGE DUE TO A GENERAL M.. | 1 0.01 76.51 PERSONALITY DISORDER | 2 0.02 76.53 PETECHIAE | 8 0.08 76.61 PHARMACEUTICAL PRODUCT COMPLAINT | 61 0.61 77.22 PHARYNGEAL ERYTHEMA | 2 0.02 77.24 PHARYNGITIS | 2 0.02 77.26 PHARYNGITIS STREPTOCOCCAL | 1 0.01 77.27 PHARYNGOLARYNGEAL PAIN | 10 0.10 77.37 PHARYNGOTONSILLITIS | 1 0.01 77.38 PHARYNX DISCOMFORT | 1 0.01 77.39 PHLEBITIS | 1 0.01 77.40 PHLEBOTHROMBOSIS | 2 0.02 77.42 PHOTOPHOBIA | 1 0.01 77.43 PHOTOPSIA | 2 0.02 77.45 PHOTOSENSITIVE RASH | 1 0.01 77.46 PHOTOSENSITIVITY REACTION | 7 0.07 77.53 PHYSICAL ASSAULT | 1 0.01 77.54 PICKWICKIAN SYNDROME | 1 0.01 77.55 PIGMENT DISPERSION SYNDROME | 1 0.01 77.56 PIGMENTATION DISORDER | 1 0.01 77.57 PIGMENTED NAEVUS | 1 0.01 77.58 PITTING OEDEMA | 4 0.04 77.62 PITUITARY TUMOUR BENIGN | 1 0.01 77.63 PITYRIASIS LICHENOIDES ET VARIOLIFORM.. | 1 0.01 77.64 PLACENTA PRAEVIA | 1 0.01 77.65 PLATELET COUNT ABNORMAL | 1 0.01 77.66 PLATELET COUNT DECREASED | 26 0.26 77.92 PLATELET COUNT INCREASED | 3 0.03 77.95 PLATELET DISORDER | 2 0.02 77.97 PLEURAL EFFUSION | 21 0.21 78.18 PLEURISY | 5 0.05 78.23 PLEURITIC PAIN | 2 0.02 78.25 PLEUROTHOTONUS | 1 0.01 78.26 PNEUMOCOCCAL INFECTION | 1 0.01 78.27 PNEUMOCYSTIS CARINII INFECTION | 1 0.01 78.28 PNEUMOCYSTIS CARINII PNEUMONIA | 4 0.04 78.32 PNEUMONIA | 51 0.51 78.83 PNEUMONIA ASPIRATION | 5 0.05 78.88 PNEUMONIA CYTOMEGALOVIRAL | 3 0.03 78.91 PNEUMONIA ESCHERICHIA | 1 0.01 78.92 PNEUMONIA KLEBSIELLA | 1 0.01 78.93 PNEUMONIA LEGIONELLA | 1 0.01 78.94 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.95 PNEUMONITIS | 2 0.02 78.97 PNEUMOPERITONEUM | 3 0.03 79.00 PNEUMOTHORAX | 1 0.01 79.01 PO2 DECREASED | 1 0.01 79.02 POIKILOCYTOSIS | 2 0.02 79.04 POISONING | 1 0.01 79.05 POLLAKIURIA | 6 0.06 79.11 POLYARTERITIS NODOSA | 1 0.01 79.12 POLYDIPSIA | 5 0.05 79.17 POLYMORPHIC LIGHT ERUPTION | 2 0.02 79.19 POLYMYOSITIS | 1 0.01 79.20 POLYNEUROPATHY | 2 0.02 79.22 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE | 1 0.01 79.23 POLYSUBSTANCE ABUSE | 1 0.01 79.24 POLYTRAUMATISM | 6 0.06 79.30 POLYURIA | 4 0.04 79.34 PORPHYRIA ACUTE | 1 0.01 79.35 PORTAL HYPERTENSION | 1 0.01 79.36 POSITRON EMISSION TOMOGRAM ABNORMAL | 1 0.01 79.37 POST PROCEDURAL BILE LEAK | 2 0.02 79.39 POST PROCEDURAL COMPLICATION | 17 0.17 79.56 POST PROCEDURAL HAEMATOMA | 1 0.01 79.57 POST PROCEDURAL HAEMORRHAGE | 5 0.05 79.62 POST PROCEDURAL NAUSEA | 1 0.01 79.63 POST PROCEDURAL PAIN | 3 0.03 79.66 POST-TRAUMATIC EPILEPSY | 1 0.01 79.67 POST-TRAUMATIC STRESS DISORDER | 1 0.01 79.68 POSTOPERATIVE ADHESION | 1 0.01 79.69 POSTOPERATIVE INFECTION | 4 0.04 79.73 POSTURE ABNORMAL | 2 0.02 79.75 POSTURING | 1 0.01 79.76 PRE-ECLAMPSIA | 1 0.01 79.77 PREGNANCY | 7 0.07 79.84 PREGNANCY ON ORAL CONTRACEPTIVE | 2 0.02 79.86 PREMATURE BABY | 6 0.06 79.92 PREMATURE LABOUR | 2 0.02 79.94 PRESCRIBED OVERDOSE | 1 0.01 79.95 PRIAPISM | 1 0.01 79.96 PROCEDURAL COMPLICATION | 2 0.02 79.98 PROCEDURAL HYPOTENSION | 1 0.01 79.99 PROCTALGIA | 1 0.01 80.00 PROCTITIS HAEMORRHAGIC | 1 0.01 80.01 PRODUCTIVE COUGH | 4 0.04 80.05 PROGESTERONE DECREASED | 1 0.01 80.06 PROSTATE CANCER | 1 0.01 80.07 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 80.08 PROSTATITIS | 1 0.01 80.09 PROTEIN S DECREASED | 1 0.01 80.10 PROTEIN S DEFICIENCY | 1 0.01 80.11 PROTEIN TOTAL DECREASED | 2 0.02 80.13 PROTEIN TOTAL INCREASED | 1 0.01 80.14 PROTEIN URINE PRESENT | 1 0.01 80.15 PROTEINURIA | 5 0.05 80.20 PROTEUS INFECTION | 3 0.03 80.23 PROTHROMBIN LEVEL DECREASED | 1 0.01 80.24 PROTHROMBIN TIME ABNORMAL | 1 0.01 80.25 PROTHROMBIN TIME PROLONGED | 4 0.04 80.29 PROTHROMBIN TIME SHORTENED | 2 0.02 80.31 PRURITUS | 37 0.37 80.68 PRURITUS ANI | 1 0.01 80.69 PRURITUS GENERALISED | 8 0.08 80.77 PSEUDOMONAS INFECTION | 1 0.01 80.78 PSORIASIS | 3 0.03 80.81 PSYCHIATRIC SYMPTOM | 4 0.04 80.85 PSYCHOGENIC PAIN DISORDER | 1 0.01 80.86 PSYCHOMOTOR AGITATION | 1 0.01 80.87 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 80.89 PSYCHOMOTOR RETARDATION | 1 0.01 80.90 PSYCHOSOMATIC DISEASE | 1 0.01 80.91 PSYCHOTIC DISORDER | 7 0.07 80.98 PULMONARY ARTERIAL PRESSURE INCREASED | 2 0.02 81.00 PULMONARY ARTERY ATRESIA | 1 0.01 81.01 PULMONARY CONGESTION | 7 0.07 81.08 PULMONARY EMBOLISM | 26 0.26 81.34 PULMONARY FIBROSIS | 9 0.09 81.43 PULMONARY GRANULOMA | 2 0.02 81.45 PULMONARY HAEMORRHAGE | 2 0.02 81.47 PULMONARY HILUM MASS | 1 0.01 81.48 PULMONARY HYPERTENSION | 8 0.08 81.56 PULMONARY HYPOPLASIA | 1 0.01 81.57 PULMONARY INFARCTION | 1 0.01 81.58 PULMONARY MYCOSIS | 1 0.01 81.59 PULMONARY OEDEMA | 16 0.16 81.75 PULMONARY SARCOIDOSIS | 1 0.01 81.76 PULMONARY THROMBOSIS | 1 0.01 81.77 PULMONARY TOXICITY | 2 0.02 81.79 PULMONARY TUBERCULOSIS | 6 0.06 81.85 PULMONARY VALVE INCOMPETENCE | 3 0.03 81.88 PULMONARY VASCULAR DISORDER | 2 0.02 81.90 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 81.91 PULSE ABSENT | 3 0.03 81.94 PUPIL FIXED | 2 0.02 81.96 PUPILLARY REFLEX IMPAIRED | 2 0.02 81.98 PURPURA | 4 0.04 82.02 PYELONEPHRITIS | 3 0.03 82.05 PYREXIA | 94 0.94 82.99 QUADRIPLEGIA | 1 0.01 83.00 RADIATION PNEUMONITIS | 1 0.01 83.01 RADICULITIS | 1 0.01 83.02 RADICULOPATHY | 1 0.01 83.03 RALES | 2 0.02 83.05 RASH | 49 0.49 83.54 RASH ERYTHEMATOUS | 11 0.11 83.65 RASH GENERALISED | 10 0.10 83.75 RASH MACULAR | 3 0.03 83.78 RASH MACULO-PAPULAR | 5 0.05 83.83 RASH PAPULAR | 5 0.05 83.88 RASH PRURITIC | 8 0.08 83.96 RASH SCALY | 2 0.02 83.98 RAYNAUD'S PHENOMENON | 1 0.01 83.99 REACTION TO DRUG EXCIPIENT | 2 0.02 84.01 RECTAL CANCER | 1 0.01 84.02 RECTAL HAEMORRHAGE | 5 0.05 84.07 RECTAL ULCER | 1 0.01 84.08 RECURRENT CANCER | 3 0.03 84.11 RED BLOOD CELL COUNT DECREASED | 13 0.13 84.24 RED BLOOD CELL SEDIMENTATION RATE INC.. | 3 0.03 84.27 REFLUX GASTRITIS | 1 0.01 84.28 REFLUX OESOPHAGITIS | 2 0.02 84.30 REFUSAL OF TREATMENT BY PATIENT | 6 0.06 84.36 REGRESSIVE BEHAVIOUR | 1 0.01 84.37 REGURGITATION OF FOOD | 1 0.01 84.38 RELATIONSHIP BREAKDOWN | 1 0.01 84.39 RENAL ARTERIOSCLEROSIS | 1 0.01 84.40 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 1 0.01 84.41 RENAL COLIC | 1 0.01 84.42 RENAL CYST | 1 0.01 84.43 RENAL DISORDER | 8 0.08 84.51 RENAL FAILURE | 37 0.37 84.88 RENAL FAILURE ACUTE | 22 0.22 85.10 RENAL FAILURE CHRONIC | 4 0.04 85.14 RENAL IMPAIRMENT | 7 0.07 85.21 RENAL INFARCT | 1 0.01 85.22 RENAL INTERSTITIAL FIBROSIS | 1 0.01 85.23 RENAL ONCOCYTOMA | 1 0.01 85.24 RENAL PAIN | 2 0.02 85.26 RENAL TRANSPLANT | 1 0.01 85.27 RENAL TUBULAR DISORDER | 1 0.01 85.28 RENAL TUBULAR NECROSIS | 6 0.06 85.34 REPETITIVE SPEECH | 1 0.01 85.35 RESPIRATION ABNORMAL | 3 0.03 85.38 RESPIRATORY ALKALOSIS | 1 0.01 85.39 RESPIRATORY ARREST | 11 0.11 85.50 RESPIRATORY DEPRESSION | 2 0.02 85.52 RESPIRATORY DISORDER | 7 0.07 85.59 RESPIRATORY DISTRESS | 8 0.08 85.67 RESPIRATORY FAILURE | 19 0.19 85.86 RESPIRATORY RATE DECREASED | 1 0.01 85.87 RESPIRATORY RATE INCREASED | 3 0.03 85.90 RESPIRATORY TRACT INFECTION | 2 0.02 85.92 RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 85.93 RESTLESS LEGS SYNDROME | 1 0.01 85.94 RESTLESSNESS | 5 0.05 85.99 RESUSCITATION | 2 0.02 86.01 RETCHING | 1 0.01 86.02 RETICULOCYTE COUNT INCREASED | 1 0.01 86.03 RETINAL DISORDER | 2 0.02 86.05 RETINAL HAEMORRHAGE | 5 0.05 86.10 RETINAL ISCHAEMIA | 1 0.01 86.11 RETINAL MICROANEURYSMS | 1 0.01 86.12 RETINAL VASCULAR OCCLUSION | 1 0.01 86.13 RETINAL VEIN OCCLUSION | 2 0.02 86.15 RETINOPATHY | 2 0.02 86.17 RETINOPATHY HYPERTENSIVE | 1 0.01 86.18 RETINOPATHY PROLIFERATIVE | 1 0.01 86.19 RETROGRADE EJACULATION | 1 0.01 86.20 RHABDOMYOLYSIS | 14 0.14 86.34 RHEUMATOID ARTHRITIS | 3 0.03 86.37 RHINITIS | 2 0.02 86.39 RHINITIS ALLERGIC | 3 0.03 86.42 RHINORRHOEA | 6 0.06 86.48 RHONCHI | 2 0.02 86.50 RIB FRACTURE | 1 0.01 86.51 ROAD TRAFFIC ACCIDENT | 8 0.08 86.59 ROSACEA | 1 0.01 86.60 ROTATOR CUFF SYNDROME | 5 0.05 86.65 SALIVA ALTERED | 1 0.01 86.66 SALIVARY HYPERSECRETION | 2 0.02 86.68 SALMONELLA SEPSIS | 1 0.01 86.69 SALMONELLOSIS | 1 0.01 86.70 SARCOIDOSIS | 2 0.02 86.72 SARCOMA | 1 0.01 86.73 SCAB | 2 0.02 86.75 SCAN MYOCARDIAL PERFUSION ABNORMAL | 1 0.01 86.76 SCAPULA FRACTURE | 1 0.01 86.77 SCAR | 2 0.02 86.79 SCHIZOPHRENIA | 2 0.02 86.81 SCIATICA | 1 0.01 86.82 SCLERITIS | 1 0.01 86.83 SCLERODERMA | 1 0.01 86.84 SCOTOMA | 2 0.02 86.86 SCRATCH | 1 0.01 86.87 SCREAMING | 4 0.04 86.91 SECRETION DISCHARGE | 1 0.01 86.92 SEDATION | 2 0.02 86.94 SELF ESTEEM DECREASED | 1 0.01 86.95 SELF INJURIOUS BEHAVIOUR | 1 0.01 86.96 SELF MUTILATION | 2 0.02 86.98 SELF-MEDICATION | 2 0.02 87.00 SENSATION OF HEAVINESS | 1 0.01 87.01 SENSATION OF PRESSURE IN EAR | 1 0.01 87.02 SENSORY DISTURBANCE | 6 0.06 87.08 SENSORY LEVEL ABNORMAL | 1 0.01 87.09 SENSORY LOSS | 1 0.01 87.10 SEPSIS | 30 0.30 87.40 SEPTIC SHOCK | 6 0.06 87.46 SEROMA | 1 0.01 87.47 SEROTONIN SYNDROME | 1 0.01 87.48 SERRATIA INFECTION | 2 0.02 87.50 SERUM FERRITIN DECREASED | 1 0.01 87.51 SERUM FERRITIN INCREASED | 1 0.01 87.52 SERUM SICKNESS | 1 0.01 87.53 SEXUAL DYSFUNCTION | 2 0.02 87.55 SHIFT TO THE LEFT | 2 0.02 87.57 SHOCK | 8 0.08 87.65 SHOCK HAEMORRHAGIC | 1 0.01 87.66 SHOULDER OPERATION | 1 0.01 87.67 SIGMOIDOSCOPY ABNORMAL | 1 0.01 87.68 SILENT MYOCARDIAL INFARCTION | 3 0.03 87.71 SIMPLE PARTIAL SEIZURES | 1 0.01 87.72 SINOATRIAL BLOCK | 2 0.02 87.74 SINUS ARREST | 3 0.03 87.77 SINUS BRADYCARDIA | 5 0.05 87.82 SINUS CONGESTION | 1 0.01 87.83 SINUS DISORDER | 3 0.03 87.86 SINUS OPERATION | 1 0.01 87.87 SINUS PAIN | 2 0.02 87.89 SINUS TACHYCARDIA | 3 0.03 87.92 SINUSITIS | 13 0.13 88.05 SJOGREN'S SYNDROME | 1 0.01 88.06 SKELETAL INJURY | 2 0.02 88.08 SKIN ATROPHY | 1 0.01 88.09 SKIN BLEEDING | 1 0.01 88.10 SKIN DESQUAMATION | 2 0.02 88.12 SKIN DISCOLOURATION | 13 0.13 88.25 SKIN DISORDER | 7 0.07 88.32 SKIN GRAFT | 1 0.01 88.33 SKIN HYPERPIGMENTATION | 1 0.01 88.34 SKIN HYPOPIGMENTATION | 1 0.01 88.35 SKIN INFECTION | 1 0.01 88.36 SKIN INFLAMMATION | 1 0.01 88.37 SKIN LACERATION | 2 0.02 88.39 SKIN LESION | 4 0.04 88.43 SKIN NECROSIS | 1 0.01 88.44 SKIN NODULE | 1 0.01 88.45 SKIN TEST POSITIVE | 2 0.02 88.47 SKIN TIGHTNESS | 2 0.02 88.49 SKIN ULCER | 4 0.04 88.53 SKIN WARM | 1 0.01 88.54 SKULL FRACTURE | 1 0.01 88.55 SLEEP APNOEA SYNDROME | 7 0.07 88.62 SLEEP DISORDER | 11 0.11 88.73 SLEEP WALKING | 1 0.01 88.74 SLUGGISHNESS | 1 0.01 88.75 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 2 0.02 88.77 SMALL FOR DATES BABY | 2 0.02 88.79 SMALL INTESTINAL HAEMORRHAGE | 1 0.01 88.80 SMALL INTESTINAL OBSTRUCTION | 1 0.01 88.81 SMOOTH MUSCLE ANTIBODY POSITIVE | 1 0.01 88.82 SNEEZING | 1 0.01 88.83 SOCIAL AVOIDANT BEHAVIOUR | 4 0.04 88.87 SODIUM RETENTION | 1 0.01 88.88 SOMNOLENCE | 42 0.42 89.30 SOMNOLENCE NEONATAL | 2 0.02 89.32 SPEECH DISORDER | 13 0.13 89.45 SPHEROCYTIC ANAEMIA | 1 0.01 89.46 SPINA BIFIDA | 1 0.01 89.47 SPINAL COLUMN STENOSIS | 2 0.02 89.49 SPINAL COMPRESSION FRACTURE | 1 0.01 89.50 SPINAL CORD COMPRESSION | 1 0.01 89.51 SPINAL CORD INJURY | 1 0.01 89.52 SPINAL FUSION SURGERY | 1 0.01 89.53 SPINAL OSTEOARTHRITIS | 1 0.01 89.54 SPLEEN CONGESTION | 1 0.01 89.55 SPLENIC INFECTION | 1 0.01 89.56 SPLENIC INJURY | 1 0.01 89.57 SPLENOMEGALY | 3 0.03 89.60 SPONDYLITIS | 1 0.01 89.61 SPONDYLOLISTHESIS ACQUIRED | 1 0.01 89.62 SPUTUM CULTURE POSITIVE | 4 0.04 89.66 SQUAMOUS CELL CARCINOMA | 2 0.02 89.68 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 89.69 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 89.70 STAPHYLOCOCCAL INFECTION | 16 0.16 89.86 STAPHYLOCOCCAL SEPSIS | 2 0.02 89.88 STARING | 2 0.02 89.90 STATUS ASTHMATICUS | 1 0.01 89.91 STATUS EPILEPTICUS | 3 0.03 89.94 STEM CELL TRANSPLANT | 1 0.01 89.95 STENT OCCLUSION | 2 0.02 89.97 STEROID WITHDRAWAL SYNDROME | 1 0.01 89.98 STEVENS-JOHNSON SYNDROME | 11 0.11 90.09 STILLBIRTH | 2 0.02 90.11 STOMA SITE REACTION | 1 0.01 90.12 STOMACH DISCOMFORT | 9 0.09 90.21 STOMATITIS | 6 0.06 90.27 STOOL ANALYSIS ABNORMAL | 1 0.01 90.28 STOOLS WATERY | 1 0.01 90.29 STRABISMUS | 2 0.02 90.31 STREPTOCOCCAL INFECTION | 2 0.02 90.33 STRESS INCONTINENCE | 1 0.01 90.34 STRESS SYMPTOMS | 9 0.09 90.43 STRIDOR | 2 0.02 90.45 STUPOR | 3 0.03 90.48 SUBARACHNOID HAEMORRHAGE | 1 0.01 90.49 SUBCLAVIAN VEIN THROMBOSIS | 1 0.01 90.50 SUBDURAL EMPYEMA | 1 0.01 90.51 SUBDURAL HAEMATOMA | 5 0.05 90.56 SUDDEN DEATH | 7 0.07 90.63 SUICIDAL IDEATION | 25 0.25 90.88 SUICIDE ATTEMPT | 13 0.13 91.01 SUPERINFECTION | 1 0.01 91.02 SUPERIOR SAGITTAL SINUS THROMBOSIS | 2 0.02 91.04 SUPRAVENTRICULAR EXTRASYSTOLES | 3 0.03 91.07 SUPRAVENTRICULAR TACHYCARDIA | 5 0.05 91.12 SURGERY | 4 0.04 91.16 SURGICAL PROCEDURE REPEATED | 3 0.03 91.19 SWELLING | 9 0.09 91.28 SWELLING FACE | 7 0.07 91.35 SWOLLEN TONGUE | 6 0.06 91.41 SYNCOPE | 23 0.23 91.64 SYNCOPE VASOVAGAL | 2 0.02 91.66 SYNOVIAL DISORDER | 1 0.01 91.67 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 91.68 SYSTEMIC LUPUS ERYTHEMATOSUS | 5 0.05 91.73 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 91.74 T-CELL LYMPHOMA | 1 0.01 91.75 T-LYMPHOCYTE COUNT DECREASED | 2 0.02 91.77 TACHYCARDIA | 18 0.18 91.95 TACHYPNOEA | 5 0.05 92.00 TARSAL TUNNEL SYNDROME | 1 0.01 92.01 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 92.02 TENDON DISORDER | 1 0.01 92.03 TENDON RUPTURE | 3 0.03 92.06 TERATOMA | 1 0.01 92.07 TESTICULAR PAIN | 1 0.01 92.08 TETANUS | 1 0.01 92.09 THERAPEUTIC AGENT TOXICITY | 4 0.04 92.13 THERAPEUTIC RESPONSE DECREASED | 5 0.05 92.18 THERAPY NON-RESPONDER | 10 0.10 92.28 THERMAL BURN | 2 0.02 92.30 THINKING ABNORMAL | 6 0.06 92.36 THIRST | 2 0.02 92.38 THIRST DECREASED | 1 0.01 92.39 THROAT IRRITATION | 5 0.05 92.44 THROAT TIGHTNESS | 7 0.07 92.51 THROMBOCYTHAEMIA | 4 0.04 92.55 THROMBOCYTOPENIA | 23 0.23 92.78 THROMBOCYTOPENIC PURPURA | 1 0.01 92.79 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.80 THROMBOSIS | 17 0.17 92.97 THYROID FUNCTION TEST ABNORMAL | 4 0.04 93.01 THYROXINE INCREASED | 1 0.01 93.02 TIBIA FRACTURE | 1 0.01 93.03 TIC | 3 0.03 93.06 TINEA PEDIS | 1 0.01 93.07 TINNITUS | 14 0.14 93.21 TOE AMPUTATION | 1 0.01 93.22 TOE DEFORMITY | 1 0.01 93.23 TONGUE DISORDER | 1 0.01 93.24 TONGUE HAEMATOMA | 1 0.01 93.25 TONGUE OEDEMA | 1 0.01 93.26 TONGUE PARALYSIS | 1 0.01 93.27 TONSILLAR DISORDER | 1 0.01 93.28 TONSILLITIS | 3 0.03 93.31 TOOTH ABSCESS | 2 0.02 93.33 TOOTH DISORDER | 2 0.02 93.35 TOOTH EXTRACTION | 1 0.01 93.36 TOOTH INFECTION | 1 0.01 93.37 TOOTH LOSS | 1 0.01 93.38 TOOTHACHE | 1 0.01 93.39 TORSADE DE POINTES | 4 0.04 93.43 TOTAL LUNG CAPACITY DECREASED | 1 0.01 93.44 TOXIC DILATATION OF COLON | 1 0.01 93.45 TOXIC EPIDERMAL NECROLYSIS | 2 0.02 93.47 TOXIC INDUCED ENCEPHALOPATHY | 3 0.03 93.50 TOXIC SKIN ERUPTION | 1 0.01 93.51 TOXICOLOGIC TEST ABNORMAL | 3 0.03 93.54 TRACHEAL DISORDER | 1 0.01 93.55 TRACHEAL MASS | 1 0.01 93.56 TRACHEAL STENOSIS | 1 0.01 93.57 TRACHEOBRONCHITIS | 1 0.01 93.58 TRANSAMINASES INCREASED | 9 0.09 93.67 TRANSIENT ISCHAEMIC ATTACK | 17 0.17 93.84 TRANSVERSE SINUS THROMBOSIS | 1 0.01 93.85 TRAUMATIC BRAIN INJURY | 3 0.03 93.88 TREATMENT NONCOMPLIANCE | 23 0.23 94.11 TREMOR | 43 0.43 94.54 TREMOR NEONATAL | 2 0.02 94.56 TRI-IODOTHYRONINE FREE INCREASED | 1 0.01 94.57 TRICHOMONIASIS | 1 0.01 94.58 TRICHOSPORON INFECTION | 1 0.01 94.59 TRICUSPID VALVE INCOMPETENCE | 7 0.07 94.66 TRIGEMINAL NEURALGIA | 1 0.01 94.67 TRIGGER FINGER | 1 0.01 94.68 TRIPLE VESSEL BYPASS GRAFT | 2 0.02 94.70 TRISMUS | 1 0.01 94.71 TRISOMY 21 | 2 0.02 94.73 TROPONIN I INCREASED | 1 0.01 94.74 TROPONIN INCREASED | 2 0.02 94.76 TROPONIN T INCREASED | 2 0.02 94.78 TRUNCUS ARTERIOSUS PERSISTENT | 1 0.01 94.79 TRYPTASE | 1 0.01 94.80 TUBERCULOSIS | 4 0.04 94.84 TUBEROUS SCLEROSIS | 2 0.02 94.86 TUNNEL VISION | 1 0.01 94.87 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 94.88 ULCER | 2 0.02 94.90 ULNA FRACTURE | 1 0.01 94.91 ULTRASOUND ABDOMEN ABNORMAL | 1 0.01 94.92 ULTRASOUND ANTENATAL SCREEN ABNORMAL | 2 0.02 94.94 ULTRASOUND LIVER ABNORMAL | 1 0.01 94.95 UMBILICAL HERNIA | 3 0.03 94.98 UNEVALUABLE EVENT | 9 0.09 95.07 UNEXPECTED THERAPEUTIC DRUG EFFECT | 3 0.03 95.10 UNINTENDED PREGNANCY | 2 0.02 95.12 UNRESPONSIVE TO PAIN STIMULI | 1 0.01 95.13 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 95.14 UPPER LIMB FRACTURE | 2 0.02 95.16 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 95.25 UPPER RESPIRATORY TRACT INFLAMMATION | 3 0.03 95.28 URINARY CASTS | 1 0.01 95.29 URINARY HESITATION | 1 0.01 95.30 URINARY INCONTINENCE | 8 0.08 95.38 URINARY RETENTION | 3 0.03 95.41 URINARY SEDIMENT PRESENT | 1 0.01 95.42 URINARY TRACT INFECTION | 21 0.21 95.63 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 95.64 URINE ANALYSIS ABNORMAL | 1 0.01 95.65 URINE CALCIUM/CREATININE RATIO INCREA.. | 1 0.01 95.66 URINE OUTPUT DECREASED | 3 0.03 95.69 URINOMA | 1 0.01 95.70 UROSEPSIS | 2 0.02 95.72 URTICARIA | 17 0.17 95.89 URTICARIA GENERALISED | 6 0.06 95.95 UTERINE CONTRACTIONS DURING PREGNANCY | 2 0.02 95.97 UTERINE LEIOMYOMA | 1 0.01 95.98 UVEITIS | 2 0.02 96.00 VAGINAL DISORDER | 1 0.01 96.01 VAGINAL HAEMORRHAGE | 5 0.05 96.06 VAGINAL HYSTERECTOMY | 1 0.01 96.07 VAGINAL MYCOSIS | 1 0.01 96.08 VAGINITIS | 1 0.01 96.09 VAGINITIS ATROPHIC | 1 0.01 96.10 VAGINITIS BACTERIAL | 1 0.01 96.11 VALVULOPLASTY CARDIAC | 1 0.01 96.12 VARICELLA | 2 0.02 96.14 VARICOPHLEBITIS | 1 0.01 96.15 VARICOSE VEIN | 1 0.01 96.16 VASCULAR DEMENTIA | 1 0.01 96.17 VASCULAR INJURY | 1 0.01 96.18 VASCULAR INSUFFICIENCY | 1 0.01 96.19 VASCULAR OCCLUSION | 1 0.01 96.20 VASCULAR STENOSIS | 1 0.01 96.21 VASCULITIS | 5 0.05 96.26 VASCULITIS CEREBRAL | 1 0.01 96.27 VASCULITIS NECROTISING | 1 0.01 96.28 VASOCONSTRICTION | 1 0.01 96.29 VASODILATATION | 2 0.02 96.31 VENOOCCLUSIVE DISEASE | 1 0.01 96.32 VENOOCCLUSIVE LIVER DISEASE | 2 0.02 96.34 VENOUS INSUFFICIENCY | 1 0.01 96.35 VENOUS PRESSURE JUGULAR INCREASED | 1 0.01 96.36 VENTRICULAR ARRHYTHMIA | 1 0.01 96.37 VENTRICULAR DYSFUNCTION | 2 0.02 96.39 VENTRICULAR DYSKINESIA | 1 0.01 96.40 VENTRICULAR EXTRASYSTOLES | 8 0.08 96.48 VENTRICULAR FAILURE | 1 0.01 96.49 VENTRICULAR FIBRILLATION | 3 0.03 96.52 VENTRICULAR HYPERTROPHY | 6 0.06 96.58 VENTRICULAR HYPOKINESIA | 1 0.01 96.59 VENTRICULAR SEPTAL DEFECT ACQUIRED | 1 0.01 96.60 VENTRICULAR TACHYCARDIA | 4 0.04 96.64 VENTRICULAR WALL THICKENING | 1 0.01 96.65 VERTEBROBASILAR INSUFFICIENCY | 1 0.01 96.66 VERTIGO | 10 0.10 96.76 VESICAL FISTULA | 1 0.01 96.77 VESTIBULAR NEURONITIS | 4 0.04 96.81 VICTIM OF CRIME | 1 0.01 96.82 VIITH NERVE PARALYSIS | 1 0.01 96.83 VIRAL HEPATITIS CARRIER | 1 0.01 96.84 VIRAL INFECTION | 7 0.07 96.91 VIRAL LOAD DECREASED | 1 0.01 96.92 VIRAL LOAD INCREASED | 4 0.04 96.96 VIRAL PERICARDITIS | 2 0.02 96.98 VIRAL UPPER RESPIRATORY TRACT INFECTION | 2 0.02 97.00 VISION BLURRED | 25 0.25 97.25 VISUAL ACUITY REDUCED | 7 0.07 97.32 VISUAL DISTURBANCE | 14 0.14 97.46 VISUAL FIELD DEFECT | 10 0.10 97.56 VITAMIN B12 DECREASED | 1 0.01 97.57 VITAMIN D DECREASED | 1 0.01 97.58 VITH NERVE PARALYSIS | 2 0.02 97.60 VITILIGO | 1 0.01 97.61 VITREOUS DETACHMENT | 1 0.01 97.62 VITREOUS HAEMORRHAGE | 1 0.01 97.63 VOCAL CORD THICKENING | 1 0.01 97.64 VOMITING | 88 0.88 98.52 WEGENER'S GRANULOMATOSIS | 1 0.01 98.53 WEIGHT DECREASED | 42 0.42 98.95 WEIGHT FLUCTUATION | 1 0.01 98.96 WEIGHT INCREASED | 24 0.24 99.20 WHEELCHAIR USER | 1 0.01 99.21 WHEEZING | 8 0.08 99.29 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.30 WHITE BLOOD CELL COUNT DECREASED | 33 0.33 99.63 WHITE BLOOD CELL COUNT INCREASED | 19 0.19 99.82 WHITE BLOOD CELL DISORDER | 2 0.02 99.84 WHITE BLOOD CELL SCAN | 1 0.01 99.85 WHITE BLOOD CELLS URINE POSITIVE | 1 0.01 99.86 WOUND | 1 0.01 99.87 WOUND COMPLICATION | 2 0.02 99.89 WOUND DEBRIDEMENT | 1 0.01 99.90 WOUND DEHISCENCE | 1 0.01 99.91 WOUND HAEMORRHAGE | 1 0.01 99.92 WOUND INFECTION | 3 0.03 99.95 WOUND INFECTION STAPHYLOCOCCAL | 2 0.02 99.97 WOUND SECRETION | 1 0.01 99.98 WRIST FRACTURE | 1 0.01 99.99 YAWNING | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015